{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":70,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":70,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"d78694197d76","filters":{"venue":"Clinical Neuropharmacology"}},"results":[{"id":"W2025416757","doi":"10.1097/00002826-200109000-00002","title":"Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms","year":2001,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":730,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Spinal cord injury; Excitotoxicity; Neuroprotection; Pathophysiology; Neuroscience; Ischemia; Intensive care medicine; Spinal cord; Pathology; Internal medicine; Psychology; Psychiatry; Glutamate receptor","authors":[{"name":"Randall J. Dumont","is_ca":true},{"name":"David O. Okonkwo","is_ca":false},{"name":"Subodh Verma","is_ca":true},{"name":"R. John Hurlbert","is_ca":true},{"name":"Paul T. Boulos","is_ca":false},{"name":"Dilantha B. Ellegala","is_ca":false},{"name":"Aaron S. Dumont","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3255204422491643,"gpt":0.587321250806737,"spread":0.2618008085575728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00119058,0.001017118,0.005772577,0.0004484249,0.0001646777,0.00003408208,0.001133041,0.001426594,0.004417369],"category_scores_gemma":[0.001479996,0.0007684968,0.002377265,0.001183985,0.0007866217,0.00006320194,0.001020183,0.005377883,0.006838057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000165812,"about_ca_system_score_gemma":0.001146324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002073374,"about_ca_topic_score_gemma":1.551245e-7,"domain_scores_codex":[0.9906184,0.002599074,0.002834882,0.00199269,0.0006141363,0.001340794],"domain_scores_gemma":[0.9950735,0.001410207,0.0008868659,0.001230808,0.000318687,0.001079949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01260091,0.000827372,0.000003581827,0.00319082,0.0006679204,0.009526643,1.571066e-7,5.057681e-9,0.0002195375,0.00009711933,0.02685858,0.9460074],"study_design_scores_gemma":[0.001214995,0.07497404,0.00002997325,0.001681055,0.005174976,0.001468689,7.993502e-7,0.000005239274,0.00001149526,0.0002089239,0.9147066,0.0005231765],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001232608,0.9849141,0.00005809872,0.0004956326,0.008023792,0.003597337,0.0001279772,0.0003254869,0.001225002],"genre_scores_gemma":[0.00002204556,0.9845632,0.0006689502,0.006276651,0.003360005,0.0004712162,0.0001633757,0.0002188467,0.004255661],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9454842,"threshold_uncertainty_score":0.9998698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007751663","doi":"10.1097/wnf.0000000000000016","title":"Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease","year":2014,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cannabis; Medicine; Rating scale; McGill Pain Questionnaire; Parkinson's disease; Disease; Observational study; Physical therapy; Visual analogue scale; Psychiatry; Psychology; Internal medicine","authors":[{"name":"Itay Lotan","is_ca":false},{"name":"T. A. Treves","is_ca":false},{"name":"Yaniv Roditi","is_ca":false},{"name":"Ruth Djaldetti","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03197668711806857,"gpt":0.3959902137891548,"spread":0.3640135266710862,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006449086,0.0002175108,0.0007471908,0.00011575,0.00007496643,0.000009907232,0.0001687926,0.000201716,0.000416941],"category_scores_gemma":[0.002105813,0.0001670901,0.0003624765,0.0001096525,0.0006905804,0.00002650383,0.000124881,0.0003097106,0.00001375262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005158222,"about_ca_system_score_gemma":0.0005515704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004436255,"about_ca_topic_score_gemma":0.000009050245,"domain_scores_codex":[0.9975976,0.0002918174,0.000697097,0.0006046975,0.0003420882,0.0004666976],"domain_scores_gemma":[0.9974686,0.0004390438,0.0001364282,0.0003385868,0.0001875408,0.001429786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02684665,0.005618917,0.2503859,0.00117233,0.0006037054,0.0007062461,0.00005676871,0.000002771578,0.01853203,0.0004962467,0.1763035,0.519275],"study_design_scores_gemma":[0.008069527,0.009765512,0.4645202,0.00002390063,0.000288669,0.00001786254,0.000003376027,0.005931109,0.000267139,0.00003501371,0.5109587,0.0001190316],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683312,0.0002401053,0.00006840613,0.02887975,0.0008371787,0.00134948,0.00007837303,0.00003429586,0.0001812141],"genre_scores_gemma":[0.9826132,0.0007393762,0.0001121089,0.005564318,0.001041214,0.0004142429,0.00002066559,0.00005052361,0.009444319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5191559,"threshold_uncertainty_score":0.6813735,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2088003671","doi":"10.1097/00002826-200109000-00003","title":"Acute Spinal Cord Injury, Part II: Contemporary Pharmacotherapy","year":2001,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Spinal cord injury; Methylprednisolone; Pharmacology; Spinal cord; Anesthesia","authors":[{"name":"Randall J. Dumont","is_ca":true},{"name":"Subodh Verma","is_ca":true},{"name":"David O. Okonkwo","is_ca":false},{"name":"R. John Hurlbert","is_ca":true},{"name":"Paul T. Boulos","is_ca":false},{"name":"Dilantha B. Ellegala","is_ca":false},{"name":"Aaron S. Dumont","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4288615500723238,"gpt":0.6179216795098523,"spread":0.1890601294375285,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001510543,0.00119759,0.006245635,0.0006330832,0.0002814189,0.0000425155,0.001275119,0.0011971,0.00722504],"category_scores_gemma":[0.0006368954,0.0009750619,0.002571193,0.001352253,0.001200475,0.0001252336,0.0008572742,0.006164797,0.003145473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001910041,"about_ca_system_score_gemma":0.002696102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005414943,"about_ca_topic_score_gemma":1.773786e-7,"domain_scores_codex":[0.9895841,0.002628963,0.003668633,0.002026314,0.0007775223,0.001314427],"domain_scores_gemma":[0.9944839,0.001384033,0.001112333,0.001179292,0.0003852372,0.001455227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02560494,0.001225365,0.00004026468,0.002515629,0.001462572,0.007413601,5.599175e-7,2.324907e-9,0.00007722223,0.00001268593,0.2262536,0.7353936],"study_design_scores_gemma":[0.003731977,0.06377152,0.00001745252,0.002187951,0.003888743,0.001698454,8.709429e-7,0.000005204488,0.00002536454,0.00001038995,0.9240159,0.0006461426],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002260379,0.9793838,0.000006068811,0.00150757,0.007943389,0.004184744,0.0001606785,0.0003274446,0.00422588],"genre_scores_gemma":[0.00006640859,0.9666385,0.0001293599,0.01275868,0.006222571,0.0004965695,0.0001816644,0.0003461269,0.01316011],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7347475,"threshold_uncertainty_score":0.99927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980626997","doi":"10.1097/wnf.0b013e31804c780e","title":"Gambling and Increased Sexual Desire With Dopaminergic Medications in Restless Legs Syndrome","year":2007,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Pramipexole; Ropinirole; Restless legs syndrome; Dopaminergic; Psychology; Levodopa; Parkinson's disease; Mania; Psychiatry; Dopamine agonist; Disease; Medicine; Internal medicine; Dopamine; Bipolar disorder; Neuroscience; Neurology; Mood","authors":[{"name":"Erika Driver‐Dunckley","is_ca":false},{"name":"Brie N. Noble","is_ca":false},{"name":"Joseph G. Hentz","is_ca":false},{"name":"Virgilio Gerald H. Evidente","is_ca":true},{"name":"John N. Caviness","is_ca":false},{"name":"James M. Parish","is_ca":false},{"name":"Lois E. Krahn","is_ca":false},{"name":"Charles H. Adler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1106238907938104,"gpt":0.4626233068166211,"spread":0.3519994160228107,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002243118,0.0002081898,0.000652283,0.0004242539,0.00007816214,0.00001545984,0.0002146124,0.0002329677,0.0001822168],"category_scores_gemma":[0.001060185,0.0001684735,0.00004777767,0.0006482834,0.0009012223,0.00006864966,0.0001551454,0.001297805,0.00006668826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005821055,"about_ca_system_score_gemma":0.0003311129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008482541,"about_ca_topic_score_gemma":0.00004982213,"domain_scores_codex":[0.9968989,0.0004968231,0.0008676041,0.0006822763,0.0004099972,0.0006443883],"domain_scores_gemma":[0.9951097,0.00352554,0.0001321767,0.0003664372,0.0001323627,0.0007337274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003291393,0.001717866,0.9039677,0.0003114352,0.0001946225,0.05193593,0.00005506221,0.00001295829,0.02570321,0.0003785594,0.0005134748,0.01191773],"study_design_scores_gemma":[0.006571608,0.002075123,0.984354,0.00007013638,0.0001268154,0.004660736,0.00006209308,0.0003932416,0.0002526369,0.00002564711,0.001238613,0.0001693622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955523,0.0002856556,0.00005456654,0.002127473,0.0001846808,0.0006146126,0.000003190841,0.00007644807,0.001101099],"genre_scores_gemma":[0.997,0.0003489651,0.0005628768,0.001340118,0.0001820487,0.00003350298,0.00001265796,0.00005067964,0.0004691608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08038624,"threshold_uncertainty_score":0.6870151,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039313127","doi":"10.1097/00002826-200203000-00010","title":"Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease With Modafinil","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Epworth Sleepiness Scale; Modafinil; Parkinson's disease; Dopamine agonist; Dopaminergic; Excessive daytime sleepiness; Medicine; Levodopa; Psychology; Internal medicine; Anesthesia; Dopamine; Disease; Psychiatry; Sleep disorder; Polysomnography; Insomnia","authors":[{"name":"Anette Nieves","is_ca":true},{"name":"Anthony E. Lang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03507027948667208,"gpt":0.318900012094994,"spread":0.2838297326083219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004424946,0.0003074958,0.0007787209,0.0001354583,0.00004157741,0.000005400588,0.000106689,0.00008639347,0.0005739303],"category_scores_gemma":[0.00006582771,0.0001979707,0.0001389813,0.0002767294,0.0002534237,0.00006986313,0.00003401327,0.0001552715,0.00006957109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007023027,"about_ca_system_score_gemma":0.0000891633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008432555,"about_ca_topic_score_gemma":0.000002261249,"domain_scores_codex":[0.9979421,0.0002287997,0.0005301501,0.0006568352,0.0002662564,0.0003758547],"domain_scores_gemma":[0.9983924,0.0002837609,0.0002444912,0.0003693766,0.0001333048,0.0005766553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01063431,0.01544538,0.955211,0.00004327784,0.0003107712,0.003404047,0.00002993744,0.00003648594,0.00002694699,0.00001616729,0.0001020475,0.01473957],"study_design_scores_gemma":[0.03554815,0.009949894,0.9443403,0.00004217142,0.0007739781,0.000007418675,0.000003371828,0.0008926468,0.00009445132,0.0000127038,0.008158862,0.0001760507],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976143,0.0002610048,0.00001053197,0.000506731,0.0002180061,0.0009638686,0.00007406788,0.00004138903,0.0003100999],"genre_scores_gemma":[0.9980791,0.0004202774,0.0002106448,0.0006931231,0.00009419242,0.0001370101,0.00004308294,0.00004743172,0.0002751165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02491384,"threshold_uncertainty_score":0.8073013,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248937293","doi":"10.1097/00002826-200001000-00007","title":"A Randomized Controlled Trial Comparing Pramipexole with Levodopa in Early Parkinson's Disease: Design and Methods of the CALM-PD Study","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pramipexole; Levodopa; Tolerability; Parkinson's disease; Medicine; Randomized controlled trial; Entacapone; Placebo; Dopaminergic; Clinical trial; Psychology; Internal medicine; Disease; Adverse effect; Dopamine","authors":[{"name":"Parkinson Study Group","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06708977375762877,"gpt":0.4175193602424132,"spread":0.3504295864847844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002770494,0.0002703988,0.002501842,0.00008573511,0.0000760512,0.00001408954,0.0001656793,0.00007995478,0.0001621121],"category_scores_gemma":[0.001050788,0.0001470956,0.0003717759,0.0002208693,0.0004529732,0.00004113449,0.00007161401,0.0004289679,0.000006251106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002085641,"about_ca_system_score_gemma":0.0002145185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002946756,"about_ca_topic_score_gemma":0.000003397316,"domain_scores_codex":[0.9889458,0.008813117,0.00111108,0.0005694292,0.0002532304,0.0003073405],"domain_scores_gemma":[0.9936435,0.005294352,0.0003182966,0.000337141,0.00006075006,0.0003459162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9325809,0.004814228,0.05805498,0.00001594689,0.0006664801,0.000569306,0.00006492803,0.00007537683,0.00007182507,0.00001330282,0.00001952123,0.003053147],"study_design_scores_gemma":[0.789598,0.002558764,0.2003495,0.00002817348,0.002452854,0.000008640539,0.000009234931,0.004348665,0.00003840059,0.00006032472,0.0004483009,0.00009913571],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865687,0.0004118757,0.0002232582,0.0003213707,0.0003893382,0.01190366,0.000002907276,0.00003144368,0.0001474745],"genre_scores_gemma":[0.9964667,0.0002471097,0.001283122,0.0006091972,0.0001047546,0.000961886,0.00000101339,0.00003075177,0.0002954761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1429829,"threshold_uncertainty_score":0.5998385,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047508973","doi":"10.1097/00002826-200601000-00009","title":"Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia","year":2006,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Research Unit on Children's Psychosocial Maladjustment","funders":"","keywords":"Clozapine; Schizophrenia (object-oriented programming); Antipsychotic; Medicine; Clinical trial; Refractory (planetary science); Psychiatry; Antipsychotic Agent; Psychology; Internal medicine","authors":[{"name":"Fayçal Mouaffak","is_ca":false},{"name":"Constantin Tranulis","is_ca":false},{"name":"Raphaël Gourévitch","is_ca":false},{"name":"Marie‐France Poirier","is_ca":false},{"name":"S. Douki","is_ca":true},{"name":"Jean-Pierre Oli","is_ca":false},{"name":"Henri L o","is_ca":false},{"name":"David Gourion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1417854540866392,"gpt":0.4910354738667544,"spread":0.3492500197801152,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003038667,0.0003995771,0.002386607,0.00027094,0.00002929082,0.00001084743,0.0002420255,0.0002242153,0.0000624509],"category_scores_gemma":[0.00005944722,0.0002003903,0.0005760046,0.0005639374,0.0005553429,0.00003159575,0.00001527281,0.0004576117,0.0000120576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007517386,"about_ca_system_score_gemma":0.001082768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002818962,"about_ca_topic_score_gemma":0.00006289006,"domain_scores_codex":[0.9961378,0.001070748,0.001635582,0.0004861012,0.0003576138,0.0003121829],"domain_scores_gemma":[0.9963,0.002333648,0.0006597803,0.0004809857,0.0001105613,0.00011498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03724557,0.01254373,0.0008900306,0.007337325,0.001307502,0.002617523,0.00004315137,0.000005920896,0.00002821777,0.0007869587,0.0004273347,0.9367667],"study_design_scores_gemma":[0.08047129,0.07587953,0.06072559,0.006272705,0.01608571,0.0007030019,0.0001854743,0.00002765059,0.0001231719,0.0002833557,0.7585564,0.0006861428],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08407892,0.9127204,0.000004725851,0.0001455496,0.0002384425,0.00251132,0.0001114121,0.0000164276,0.0001728053],"genre_scores_gemma":[0.01130875,0.9873869,0.0006056744,0.00003701076,0.0002306171,0.00015179,0.0001933461,0.00004166975,0.00004423046],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9360806,"threshold_uncertainty_score":0.817168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W44850464","doi":"10.1097/wnf.0b013e3180340319","title":"The Effect of Duloxetine on Primary Pain Symptoms in Parkinson Disease","year":2007,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Duloxetine; McGill Pain Questionnaire; Duloxetine Hydrochloride; Visual analogue scale; Parkinson's disease; Brief Pain Inventory; Rating scale; Medicine; Quality of life (healthcare); Physical therapy; Psychology; Disease; Chronic pain; Internal medicine","authors":[{"name":"Ruth Djaldetti","is_ca":false},{"name":"Shlomit Yust‐Katz","is_ca":false},{"name":"Vadim Kolianov","is_ca":false},{"name":"Eldad Melamed","is_ca":false},{"name":"Ron Dabby","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01790105886594781,"gpt":0.3595551155893931,"spread":0.3416540567234453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002839641,0.0002036912,0.000514639,0.00009736409,0.00006484535,0.0000044212,0.0001522197,0.00009997333,0.00006277947],"category_scores_gemma":[0.001683661,0.0001259765,0.0002591148,0.0001989268,0.0002334065,0.00001733758,0.00006928278,0.0004148141,0.00005741441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005336654,"about_ca_system_score_gemma":0.00007368058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003002117,"about_ca_topic_score_gemma":0.000001836921,"domain_scores_codex":[0.9970041,0.001208598,0.0007108421,0.0004327023,0.0002330362,0.000410734],"domain_scores_gemma":[0.9915413,0.007461236,0.0001717794,0.0003274049,0.00003244643,0.000465785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02742887,0.001454665,0.7730198,0.000106839,0.0001346035,0.004086127,0.000004220762,0.000005173689,0.001625193,0.00006637988,0.0008679554,0.1912002],"study_design_scores_gemma":[0.009134442,0.006113371,0.9136155,0.00004535748,0.0002573904,0.000004849184,0.000001187029,0.0001788269,0.00142938,0.00003872915,0.0690912,0.00008980693],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961758,0.0005047304,0.00001871,0.0009276471,0.0008526323,0.0007862392,0.000009434797,0.00004042692,0.0006844063],"genre_scores_gemma":[0.9946571,0.0004254601,0.00002042024,0.00440113,0.0002525718,0.00004447092,0.00001338204,0.00002914441,0.0001563454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1911104,"threshold_uncertainty_score":0.5137172,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018810282","doi":"10.1097/00002826-200105000-00005","title":"Double-blind, Crossover, Placebo-controlled Trial of Bromocriptine in Patients with Sleep Bruxism","year":2001,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Temporomandibular Joint Disorders","field":"Health Professions","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Bromocriptine; Placebo; Crossover study; Medicine; Sleep Bruxism; Anesthesia; Internal medicine; Electromyography; Hormone; Prolactin; Physical medicine and rehabilitation","authors":[{"name":"Gilles Lavigne","is_ca":true},{"name":"Jean‐Paul Soucy","is_ca":false},{"name":"Frank Lobbezoo","is_ca":false},{"name":"Christiane Manzini","is_ca":true},{"name":"Pierre J. Blanchet","is_ca":true},{"name":"Jacques Montplaisir","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08322264891113389,"gpt":0.461242579060787,"spread":0.3780199301496531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001566908,0.0003129757,0.001462503,0.0002363616,0.0002001395,0.000005553848,0.0004073664,0.0004514157,0.001039263],"category_scores_gemma":[0.001163916,0.0002479961,0.0002342986,0.0004306741,0.0003649505,0.0001303853,0.0002240864,0.001800511,0.000209761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005900797,"about_ca_system_score_gemma":0.0002978085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007970587,"about_ca_topic_score_gemma":0.0001590841,"domain_scores_codex":[0.9928456,0.002678337,0.002626465,0.0006749024,0.0003634802,0.0008112022],"domain_scores_gemma":[0.9940886,0.003870978,0.001042362,0.0004709171,0.0002622486,0.00026493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7598275,0.002586054,0.2329238,0.00003136467,0.00009678983,0.00007353192,0.00008464687,0.00002257032,0.00003868954,0.00005403048,0.003979336,0.0002816847],"study_design_scores_gemma":[0.8818102,0.003633033,0.1003219,0.00002730592,0.0001228379,0.000001010845,0.00002361714,0.00008206285,0.000004133435,0.00005419873,0.01371857,0.0002010667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816843,0.00003570576,0.00001720892,0.002011542,0.004841778,0.008259929,0.00001170958,0.000092168,0.003045609],"genre_scores_gemma":[0.9945862,0.00009784252,0.0001322194,0.002936252,0.000445778,0.0005757035,0.00002644744,0.00006915256,0.001130353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1326019,"threshold_uncertainty_score":0.9999973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980632974","doi":"10.1097/wnf.0b013e31827db49b","title":"Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease","year":2013,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Parkwood Institute","funders":"","keywords":"Medicine; Adverse effect; Pharmacokinetics; Placebo; Anesthesia; Pharmacodynamics; Cerebrospinal fluid; Gastroenterology; Internal medicine; Pathology","authors":[{"name":"Jaren W. Landen","is_ca":false},{"name":"Qinying Zhao","is_ca":false},{"name":"Sharon Cohen","is_ca":false},{"name":"Michael Borrie","is_ca":true},{"name":"Mark Woodward","is_ca":false},{"name":"Clare B. Billing","is_ca":false},{"name":"Kelly R. Bales","is_ca":false},{"name":"Christine Alvey","is_ca":false},{"name":"Fred McCush","is_ca":false},{"name":"Jerry Yang","is_ca":false},{"name":"James W. Kupiec","is_ca":false},{"name":"Martin M. Bednar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05818489725870915,"gpt":0.3828051632185218,"spread":0.3246202659598126,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002131598,0.0002274434,0.0008369448,0.0002225855,0.00003662262,0.000005266908,0.0001278718,0.00009835115,0.0005778428],"category_scores_gemma":[0.0001617665,0.0001760007,0.0001043987,0.0003151555,0.0005480126,0.00007489184,0.0001449778,0.000348327,0.00005477597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002653848,"about_ca_system_score_gemma":0.0004211206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007502784,"about_ca_topic_score_gemma":0.00000646437,"domain_scores_codex":[0.9974439,0.000518879,0.0007988429,0.0005260207,0.000221569,0.0004907671],"domain_scores_gemma":[0.997402,0.0009046599,0.000176136,0.000234743,0.000233443,0.001049011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2295019,0.03722968,0.5123551,0.0007433239,0.01801548,0.01039916,0.0004130656,0.0001684994,0.1517363,0.0001360546,0.00262016,0.03668136],"study_design_scores_gemma":[0.02309526,0.008696906,0.9511412,0.0000726119,0.002238976,0.00005048123,0.00002004852,0.0006116225,0.01362537,0.00006497737,0.0001659859,0.000216497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938141,0.002055393,0.000004241698,0.002002939,0.0001718811,0.001711838,0.00003769408,0.00002201368,0.0001799053],"genre_scores_gemma":[0.9968064,0.0007665047,0.0002160517,0.001960091,0.00009634395,0.0000870447,0.00001430022,0.00003687152,0.00001636952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4387862,"threshold_uncertainty_score":0.7177102,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045089703","doi":"10.1097/00002826-200307000-00013","title":"Metabolite Changes Resulting From Treatment in Children With ADHD: A 1H-MRS Study","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Institute for Biodiagnostics; Dalhousie University; Izaak Walton Killam Health Centre; Nova Scotia Health Authority","funders":"Eli Lilly Canada; Nova Scotia Health Research Foundation","keywords":"Phosphocreatine; Creatine; Glutamine; Metabolite; Striatum; Choline; Glutamate receptor; Neurochemical; Internal medicine; Glutamatergic; Attention deficit hyperactivity disorder; Medicine; Endocrinology; Ventral striatum; Psychology; Chemistry; Biochemistry; Dopamine; Psychiatry; Amino acid","authors":[{"name":"Normand Carrey","is_ca":true},{"name":"Frank P. MacMaster","is_ca":true},{"name":"Joshua Fogel","is_ca":false},{"name":"Sandra J. Sparkes","is_ca":true},{"name":"Daniel A. Waschbusch","is_ca":true},{"name":"S. O' Sullivan","is_ca":true},{"name":"Mathias V. Schmidt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1213473788737947,"gpt":0.4435567764725035,"spread":0.3222093975987088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004015811,0.0002553633,0.0007821742,0.0001399188,0.00005786056,0.00001173669,0.00009240694,0.0001188672,0.0003209465],"category_scores_gemma":[0.0007638816,0.0001928657,0.0001104847,0.0003163026,0.0001342395,0.00005273603,0.00004360353,0.000562282,0.0001176651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000044631,"about_ca_system_score_gemma":0.0001151516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002024993,"about_ca_topic_score_gemma":0.0001360978,"domain_scores_codex":[0.9968041,0.001317406,0.0005650695,0.0007512007,0.0001895594,0.0003726851],"domain_scores_gemma":[0.998202,0.0009904105,0.0001843707,0.0003545417,0.00006637596,0.0002022457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008397627,0.006010263,0.9856837,0.000002547085,0.0004541368,0.0004484517,0.0002859201,0.00001655302,0.001783699,0.000005657068,0.00005455554,0.004414772],"study_design_scores_gemma":[0.02035642,0.003602947,0.9697301,0.000007916142,0.0007856141,0.00006567873,0.0007766013,0.00004121269,0.0001846818,0.000006254584,0.004268504,0.0001740108],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958424,0.0002563557,0.000004432055,0.001460694,0.0004502316,0.001621251,0.00001798992,0.0000782039,0.0002684216],"genre_scores_gemma":[0.9964447,0.0002375073,0.0002141226,0.002138328,0.0003612957,0.0001345665,0.00002037093,0.00004813783,0.000400958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01951666,"threshold_uncertainty_score":0.7864836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980849388","doi":"10.1097/01.wnf.0000174932.82134.e2","title":"Quetiapine for Insomnia in Parkinson Disease","year":2005,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Quetiapine; Pittsburgh Sleep Quality Index; Epworth Sleepiness Scale; Insomnia; Internal medicine; Medicine; Excessive daytime sleepiness; Rating scale; Polysomnography; Hypnotic; Psychology; Anesthesia; Sleep disorder; Psychiatry; Schizophrenia (object-oriented programming); Sleep quality","authors":[{"name":"Carlos Juri","is_ca":true},{"name":"Pedro Chaná","is_ca":true},{"name":"John Frederick D. Tapia","is_ca":true},{"name":"Carolina Kunstmann","is_ca":true},{"name":"Teresa Parrao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1265459834756793,"gpt":0.5002710878749101,"spread":0.3737251043992308,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000692072,0.0001543409,0.0005090309,0.0001923951,0.00003617542,0.000009085902,0.0002064688,0.0001390145,0.0005023231],"category_scores_gemma":[0.002263983,0.0001389038,0.0002076051,0.0002356547,0.0002605467,0.00006390463,0.0001100701,0.0006854904,0.0003811086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006674686,"about_ca_system_score_gemma":0.0002809589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003995147,"about_ca_topic_score_gemma":0.00000564971,"domain_scores_codex":[0.9976132,0.0003654561,0.0007487352,0.0005542191,0.0001989876,0.0005193864],"domain_scores_gemma":[0.9973416,0.0015293,0.0000777251,0.0003121152,0.00009697812,0.0006423363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01451131,0.006276665,0.7650221,0.0005034597,0.0001205536,0.003759379,0.00003417565,0.0001547029,0.01701704,0.0006306124,0.06479334,0.1271766],"study_design_scores_gemma":[0.006519618,0.000682504,0.4594436,0.00001938977,0.00004837877,0.00002801741,0.000001176229,0.003703334,0.0002299253,0.00006222873,0.5291673,0.00009458454],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675788,0.0005042959,0.00003627348,0.02976502,0.0003956967,0.001196896,0.000009117079,0.0000661781,0.0004477696],"genre_scores_gemma":[0.9877145,0.001256948,0.000759011,0.0074529,0.001110581,0.0002037912,0.00001425481,0.00004726536,0.001440695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4643739,"threshold_uncertainty_score":0.5664334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W117490009","doi":"10.1097/wnf.0b013e3181c46f48","title":"A Prospective, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Type A Botulinum Toxins Botox and Prosigne in the Treatment of Cervical Dystonia","year":2010,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cervical dystonia; Spasmodic Torticollis; Medicine; Tolerability; Randomized controlled trial; Botulinum toxin; Dystonia; Quality of life (healthcare); Adverse effect; Anesthesia; Torticollis; Rating scale; Surgery; Internal medicine; Psychology","authors":[{"name":"Elizabeth Maria Aparecida Barasnevicius Quagliato","is_ca":false},{"name":"Edmur Franco Carelli","is_ca":false},{"name":"Maura Aparecida Viana","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06563286935701265,"gpt":0.396070542860635,"spread":0.3304376735036223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001060204,0.0002117339,0.001149191,0.00006173794,0.00008339952,0.000008991455,0.0001786237,0.0002129632,0.00004494027],"category_scores_gemma":[0.0004447059,0.00009716884,0.0001490727,0.0003040482,0.00157289,0.0000206089,0.00009086567,0.0009884211,0.000003059312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006256405,"about_ca_system_score_gemma":0.00005471292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000249851,"about_ca_topic_score_gemma":0.00003508833,"domain_scores_codex":[0.9970823,0.001058644,0.001005878,0.000448524,0.0001680917,0.0002365967],"domain_scores_gemma":[0.9946582,0.004623557,0.0002254601,0.0002988943,0.00007554434,0.0001183737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7108954,0.01353351,0.2636826,0.0000465753,0.0003755524,0.0001785746,0.001479472,0.00001443719,0.007914523,0.0004073122,0.00002736695,0.001444656],"study_design_scores_gemma":[0.478698,0.009367881,0.5095531,0.000009687966,0.0006935563,0.00007027898,0.00009456556,0.0007579756,0.0002183047,0.00008060755,0.0003712583,0.00008473354],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899305,0.0003336128,0.000001370589,0.003103147,0.0003902451,0.005902119,0.000001679877,0.00001892537,0.000318426],"genre_scores_gemma":[0.9967974,0.002197963,0.0000311047,0.0007610883,0.00009107511,0.00006970194,0.00000124313,0.00001589277,0.0000345692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2458705,"threshold_uncertainty_score":0.579538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018391979","doi":"10.1097/00002826-200007000-00005","title":"Sustained Cabergoline Treatment Reverses Levodopa-Induced Dyskinesias in Parkinsonian Monkeys","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Cabergoline; Benserazide; Dyskinesia; Levodopa; Dopamine; Medicine; Parkinson's disease; MPTP; Decarboxylase inhibitor; Dopamine agonist; Agonist; Dopamine receptor D2; Internal medicine; Anesthesia; Pharmacology; Endocrinology; Receptor; Dopaminergic; Disease; Prolactin","authors":[{"name":"Abdallah Hadj Tahar","is_ca":true},{"name":"Laurent Grégoire","is_ca":true},{"name":"Evelyne Bangassoro","is_ca":true},{"name":"Paul J. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06180993642833334,"gpt":0.3893135241711484,"spread":0.3275035877428151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001839815,0.0004057032,0.0009503787,0.000183499,0.00008946373,0.00001317666,0.0001556963,0.0002383074,0.004137901],"category_scores_gemma":[0.0001937489,0.0003351093,0.0003502956,0.0003737268,0.0001236213,0.00007225907,0.00005949269,0.000377665,0.0006910533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002184487,"about_ca_system_score_gemma":0.0003068993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001166538,"about_ca_topic_score_gemma":0.00004161379,"domain_scores_codex":[0.9967877,0.0005227002,0.0009095718,0.0008887204,0.000201534,0.0006898012],"domain_scores_gemma":[0.9982344,0.000489657,0.000127852,0.0004494902,0.000071852,0.0006267574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02106907,0.02646527,0.2367309,0.0001364264,0.001243893,0.08258735,0.0002231149,0.0000838995,0.01980697,0.0001803349,0.006863059,0.6046097],"study_design_scores_gemma":[0.0495517,0.009479269,0.6937565,0.00007108063,0.001284088,0.0003610921,0.00005994932,0.001440828,0.006206837,0.0002558895,0.2368843,0.0006484634],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919433,0.0002160772,0.000001858776,0.002611743,0.0006333594,0.000953904,0.00002330386,0.0001409887,0.003475466],"genre_scores_gemma":[0.9867406,0.003005113,0.0002097968,0.004351181,0.0005108152,0.0001212483,0.00003760283,0.00006360506,0.004960035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6039612,"threshold_uncertainty_score":0.9999101,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2943068831","doi":"10.1097/wnf.0000000000000344","title":"Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study","year":2019,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Curcumin; Schizophrenia (object-oriented programming); Placebo; Antipsychotic; Positive and Negative Syndrome Scale; Medicine; Internal medicine; Adverse effect; Randomized controlled trial; Depression (economics); Psychiatry; Clinical trial; Psychology; Psychosis; Pharmacology","authors":[{"name":"Chanoch Miodownik","is_ca":false},{"name":"Vladimir Lerner","is_ca":false},{"name":"Natalie Kudkaeva","is_ca":false},{"name":"Paul P. Lerner","is_ca":false},{"name":"Artashez Pashinian","is_ca":false},{"name":"Yuly Bersudsky","is_ca":false},{"name":"Ronen Eliyahu","is_ca":false},{"name":"Anatoly Kreinin","is_ca":false},{"name":"Joseph Bergman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02028843139327818,"gpt":0.3621573988056611,"spread":0.3418689674123829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006157233,0.0003909506,0.001183771,0.0001707459,0.00005723701,0.00002138049,0.0004226536,0.0002365337,0.0003220167],"category_scores_gemma":[0.0002751528,0.0002774467,0.0002784878,0.0003312435,0.0002432687,0.000004922921,0.0001543536,0.000349225,0.0009571044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006707864,"about_ca_system_score_gemma":0.0002931073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002160784,"about_ca_topic_score_gemma":0.00007171307,"domain_scores_codex":[0.9961855,0.0008786722,0.001001162,0.001187694,0.0002584538,0.0004885072],"domain_scores_gemma":[0.9976826,0.0009240312,0.0002415067,0.0006925353,0.0001021326,0.0003571544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9625195,0.006487681,0.02393884,0.000008560463,0.0004284732,0.00002598355,0.00002147328,0.0001097475,0.003902267,0.00003195491,0.0004310706,0.002094421],"study_design_scores_gemma":[0.9598595,0.01846942,0.01522852,0.00001270528,0.0002478314,0.000002917693,0.000008103104,0.00006532059,0.0008728829,0.00001037655,0.004916616,0.0003057422],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860094,0.00005366992,0.00003174384,0.0005808445,0.0007216179,0.01222479,0.00001430251,0.0000283172,0.0003352718],"genre_scores_gemma":[0.9948546,0.00005684573,0.00005591401,0.001651856,0.0003882853,0.002091804,0.00007064198,0.00005457089,0.0007754604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01198174,"threshold_uncertainty_score":0.9999678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052643285","doi":"10.1097/00002826-200107000-00003","title":"Methylphenidate Increases the Motor Effects of L-Dopa in Parkinson's Disease: A Pilot Study","year":2001,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke","keywords":"Methylphenidate; Anxiety; Levodopa; Anesthesia; Psychology; Dyskinesia; Mood; Dopamine; Placebo; Carbidopa; Stroop effect; Medicine; Parkinson's disease; Cognition; Psychiatry; Internal medicine; Attention deficit hyperactivity disorder; Neuroscience; Disease","authors":[{"name":"Richard Camicioli","is_ca":true},{"name":"Eric S. Lea","is_ca":false},{"name":"John G. Nutt","is_ca":false},{"name":"Gary Sexton","is_ca":false},{"name":"Barry Oken","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05245199753721957,"gpt":0.3818614101433815,"spread":0.329409412606162,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005230202,0.0002614999,0.0007301484,0.0001306612,0.00006837465,0.000008187234,0.0002669476,0.0000383056,0.0001939068],"category_scores_gemma":[0.001626616,0.0001739149,0.0002004443,0.0003595247,0.0002310247,0.00004844533,0.000180552,0.0003970067,0.00007340586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003115293,"about_ca_system_score_gemma":0.0001522657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001377463,"about_ca_topic_score_gemma":0.00002031294,"domain_scores_codex":[0.996547,0.001449851,0.0007286256,0.0006095052,0.0002761628,0.0003888663],"domain_scores_gemma":[0.9959996,0.00272974,0.0002089258,0.0004878707,0.00008292632,0.0004909008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01532109,0.03263186,0.9188526,0.000104959,0.0004379087,0.01826116,0.0000251117,0.000003915512,0.006896256,0.00002545061,0.0003968975,0.007042784],"study_design_scores_gemma":[0.01368114,0.00994823,0.9639504,0.00003469417,0.001106988,0.00003008805,0.00001651568,0.0001574373,0.0002764302,0.0001122823,0.01056211,0.0001237103],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953516,0.001044498,0.000006322706,0.000631215,0.0006642409,0.002135325,0.00001905565,0.00005637598,0.00009142711],"genre_scores_gemma":[0.995059,0.001347466,0.0000411954,0.002766887,0.0002318101,0.0003129011,0.000006830852,0.00003832837,0.0001956028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04509777,"threshold_uncertainty_score":0.7092044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2920938584","doi":"10.1097/wnf.0000000000000326","title":"Real-World Experience With VMAT2 Inhibitors","year":2019,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dystonia Medical Research Foundation Canada; WiLAN (Canada)","funders":"","keywords":"Tetrabenazine; Tics; Medicine; Medical prescription; Dose; Internal medicine; Vesicular monoamine transporter; Pediatrics; Psychiatry; Monoamine neurotransmitter; Pharmacology; Dopamine","authors":[{"name":"Nicki Niemann","is_ca":false},{"name":"Joseph Jankovic","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06645725897481558,"gpt":0.4016426721567979,"spread":0.3351854131819824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001436804,0.0002759115,0.0004112811,0.000112312,0.0001102189,0.00003885742,0.0005746881,0.00006547779,0.002066859],"category_scores_gemma":[0.0006611196,0.0002232554,0.0001367177,0.0004872643,0.0006709407,0.0001023066,0.0002529694,0.0004719375,0.002536743],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001847478,"about_ca_system_score_gemma":0.0001030413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006684698,"about_ca_topic_score_gemma":0.000003753693,"domain_scores_codex":[0.9962373,0.001044155,0.0006392591,0.001230703,0.0003216035,0.0005269347],"domain_scores_gemma":[0.9967039,0.002116616,0.0002125562,0.0005319113,0.00006636456,0.0003686491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004545729,0.0004425045,0.1186776,0.00001410743,0.000006380754,0.0003383696,0.00004815414,0.0001573275,0.8747842,0.0006156308,0.003683107,0.0007780719],"study_design_scores_gemma":[0.002073379,0.00118338,0.1138404,0.000009477923,0.00003403181,0.00002573277,0.00001586801,0.0002424553,0.8521393,0.00004291267,0.03002867,0.0003643816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886807,0.000006726437,0.000005459167,0.0008552852,0.002938596,0.0006035074,0.000009945972,0.0001838802,0.006715937],"genre_scores_gemma":[0.9828491,0.0001408393,0.00010237,0.01311012,0.0003286993,0.00006351987,0.000001075919,0.00005585027,0.003348395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02634556,"threshold_uncertainty_score":0.9988454,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993332355","doi":"10.1097/00002826-200401000-00008","title":"Effect of Riluzole on Dyskinesia and Duration of the ON State in Parkinson Disease Patients","year":2004,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Riluzole; Dyskinesia; Placebo; Levodopa; Apomorphine; Parkinson's disease; Anesthesia; Medicine; Psychology; Amyotrophic lateral sclerosis; Internal medicine; Disease; Dopaminergic; Dopamine","authors":[{"name":"Claudia Aparecida Braz","is_ca":true},{"name":"Vanderci Borges","is_ca":false},{"name":"Henrique Ballalai Ferraz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0163435614235081,"gpt":0.3469000184184506,"spread":0.3305564569949425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001853989,0.0001249783,0.0003309178,0.00006317966,0.00002257011,0.000001605707,0.00006073353,0.00004666003,0.000015308],"category_scores_gemma":[0.0004172344,0.00007772975,0.0001063077,0.000113023,0.0001217006,0.00001931984,0.00003879737,0.0001699806,0.0000101039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002657104,"about_ca_system_score_gemma":0.00005089965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006889175,"about_ca_topic_score_gemma":0.000001423982,"domain_scores_codex":[0.9985945,0.0004176819,0.0004300803,0.000266949,0.000158112,0.00013266],"domain_scores_gemma":[0.9989932,0.0004610091,0.0001833507,0.0001760484,0.00003340748,0.000153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01334323,0.003173495,0.9715605,0.0001305583,0.00005069152,0.0001862868,0.00001784385,0.0001226019,0.002030177,0.00006015958,0.00004202916,0.009282356],"study_design_scores_gemma":[0.0133174,0.005809031,0.9679352,0.00007581603,0.0001635911,8.389151e-7,3.673083e-7,0.00007320749,0.01206804,0.0001556636,0.000354181,0.00004663731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984758,0.00003171367,0.00000155477,0.0003190501,0.0004030654,0.0006834714,0.00002915817,0.0000084868,0.00004771],"genre_scores_gemma":[0.9987602,0.0001391254,0.000006199511,0.001005917,0.00003010739,0.00002305569,0.000006970782,0.00001299639,0.00001538299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01003786,"threshold_uncertainty_score":0.3169727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2882844","doi":"","title":"Role of Remote Sensing in Disaster Management","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Synthetic Aperture Radar (SAR) Applications and Techniques","field":"Engineering","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute for Catastrophic Loss Reduction","keywords":"Remote sensing; Emergency management; Computer science; Business; Computer security; Geography; Political science","authors":[{"name":"Nirupama","is_ca":false},{"name":"Slobodan P. Simonović","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02484973261665826,"gpt":0.304537285211696,"spread":0.2796875525950377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001120989,0.00008996323,0.0002027112,0.00006560567,0.00001131788,0.000002709939,0.0001218069,0.00007478141,0.0001888021],"category_scores_gemma":[0.00001945847,0.00008795014,0.00006037857,0.0001334604,0.00007782209,0.00001729057,0.00004973077,0.0002011525,0.00005185596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001129994,"about_ca_system_score_gemma":0.000001011532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002017033,"about_ca_topic_score_gemma":0.000001053517,"domain_scores_codex":[0.9991367,0.00006034576,0.0004252821,0.0001701874,0.00005252168,0.0001549102],"domain_scores_gemma":[0.9994605,0.0002546135,0.00003376926,0.000194884,0.00001103569,0.00004515707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005573995,0.00004806587,0.00008274912,0.00001629078,0.00001573956,0.00002421707,0.00002693724,0.000006270134,0.002360425,0.0001553486,0.001011336,0.9962471],"study_design_scores_gemma":[0.0006474576,0.00007506774,0.003623814,0.00002186578,0.00004309856,0.00001831725,0.00002516939,0.2164952,0.005000163,0.001272728,0.7726018,0.0001753388],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8919277,0.0005549499,0.0465056,0.0006824759,0.0006177647,0.00060571,0.000004586904,0.0004562296,0.05864499],"genre_scores_gemma":[0.8732998,0.0009595221,0.1251335,0.0004230513,0.00007412992,0.000001393826,5.756087e-7,0.00002541426,0.00008262081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9960717,"threshold_uncertainty_score":0.3586502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963544666","doi":"10.1097/wnf.0b013e31819a68b5","title":"Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia","year":2009,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Otsuka Pharmaceutical","keywords":"Aripiprazole; Schizophrenia (object-oriented programming); Positive and Negative Syndrome Scale; Neurocognitive; Wisconsin Card Sorting Test; Psychology; Brief Psychiatric Rating Scale; Akathisia; Rating scale; Scale for the Assessment of Negative Symptoms; Psychiatry; Cognition; Trail Making Test; Global Assessment of Functioning; Clinical psychology; Psychosis; Antipsychotic; Neuropsychology; Developmental psychology","authors":[{"name":"Sung‐Wan Kim","is_ca":false},{"name":"Il‐Seon Shin","is_ca":false},{"name":"Jae‐Min Kim","is_ca":false},{"name":"Jeong-Hoon Lee","is_ca":false},{"name":"Yo‐Han Lee","is_ca":false},{"name":"Sujin Yang","is_ca":false},{"name":"Jin‐Sang Yoon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02359581114582315,"gpt":0.3757193929095006,"spread":0.3521235817636775,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003661707,0.0001804044,0.0006586896,0.0001603028,0.00002840156,0.000006694443,0.0001551862,0.0001198367,0.00006518065],"category_scores_gemma":[0.0005730314,0.0001340695,0.0001059797,0.0003478922,0.00008317413,0.0000418175,0.00005408004,0.0006224673,0.00006853711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004056365,"about_ca_system_score_gemma":0.0001429524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006933682,"about_ca_topic_score_gemma":0.000004897855,"domain_scores_codex":[0.9977518,0.000532073,0.0005948091,0.0005033343,0.0002707418,0.0003472592],"domain_scores_gemma":[0.9976104,0.00145569,0.00009237807,0.0002961994,0.0001225293,0.000422774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3536862,0.003078906,0.6198571,0.00001839018,0.0000845039,0.0002851372,0.000007769797,0.00001466752,0.004474601,0.00008494424,0.00004717957,0.01836061],"study_design_scores_gemma":[0.03214027,0.008193637,0.9571451,0.0001082783,0.00009385408,0.000002983717,0.000001331847,0.0000671044,0.00175606,0.00034902,0.00003881062,0.000103539],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978969,0.00003254256,0.00008386301,0.0006819975,0.0003110997,0.0009171235,0.00001219735,0.00003039966,0.0000339172],"genre_scores_gemma":[0.9960406,0.00003240901,0.002813715,0.0009469368,0.0001122348,0.00001187853,0.00002018937,0.00001880412,0.000003197674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3372881,"threshold_uncertainty_score":0.5467196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109594309","doi":"10.1097/01.wnf.0000236763.16032.60","title":"Plasma Homocysteine Levels and Parkinson Disease","year":2006,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Internal medicine; Montreal Cognitive Assessment; Medicine; Homocysteine; Parkinson's disease; Depression (economics); Psychosis; Dementia; Rating scale; Beck Depression Inventory; Gastroenterology; Disease; Psychology; Psychiatry","authors":[{"name":"Sharon Hassin‐Baer","is_ca":false},{"name":"Oren S. Cohen","is_ca":false},{"name":"Eli Vakil","is_ca":false},{"name":"Ben‐Ami Sela","is_ca":false},{"name":"Zeev Nitsan","is_ca":false},{"name":"Roseline Schwartz","is_ca":false},{"name":"Joab Chapman","is_ca":false},{"name":"David Tanné","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07257440747081113,"gpt":0.413837142456368,"spread":0.3412627349855569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000285417,0.0001363153,0.0003546154,0.00008702635,0.00007013611,0.00001357079,0.00009162844,0.0001074977,0.000427988],"category_scores_gemma":[0.0003799112,0.0001111031,0.0001110585,0.0001447527,0.0003841405,0.00004249739,0.0001249646,0.0004816748,0.0002351398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001297018,"about_ca_system_score_gemma":0.0001010535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001246377,"about_ca_topic_score_gemma":0.000002795011,"domain_scores_codex":[0.9983384,0.0002429648,0.0004611412,0.000438714,0.0001724076,0.0003463748],"domain_scores_gemma":[0.9984717,0.0007453088,0.00005437072,0.0002022909,0.00007303451,0.0004532646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005538395,0.002697163,0.7896646,0.0002731997,0.0001653656,0.01385676,0.00001026813,0.000008721543,0.07271487,0.0005282253,0.06380905,0.05073334],"study_design_scores_gemma":[0.00452374,0.0008679412,0.8011668,0.000009871519,0.0001318222,0.00008941811,0.000001386806,0.00137106,0.0007095871,0.00007682046,0.1909519,0.00009968371],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925741,0.0004033904,0.000006078916,0.004673304,0.0004577349,0.0003253403,0.00001743715,0.00007011517,0.00147252],"genre_scores_gemma":[0.991331,0.0003075929,0.0001083677,0.002744563,0.0008708135,0.00001595702,0.00001153643,0.00002576451,0.004584422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1271429,"threshold_uncertainty_score":0.4686169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033461129","doi":"10.1097/00002826-200309000-00006","title":"Lamotrigine Treatment for Post-Stroke Pathological Laughing and Crying","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Infant Health and Development","field":"Health Professions","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Lamotrigine; Crying; Stroke (engine); Medicine; Mood; Pathological; Anesthesia; Serotonin reuptake inhibitor; Epilepsy; Psychology; Pediatrics; Antidepressant; Psychiatry; Internal medicine","authors":[{"name":"Rajamannar Ramasubbu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2165462839635849,"gpt":0.5531428008630249,"spread":0.33659651689944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001499017,0.0001993964,0.0005276857,0.00006986232,0.0007404637,0.00000557679,0.00009228358,0.0003157441,0.0004068607],"category_scores_gemma":[0.002496369,0.0001496169,0.0001173895,0.00006554349,0.0001341048,0.00004310243,0.00006600929,0.0006434177,0.0001671951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006996786,"about_ca_system_score_gemma":0.0004539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000775735,"about_ca_topic_score_gemma":0.000006874202,"domain_scores_codex":[0.9959306,0.001629379,0.001059339,0.000516307,0.0000703754,0.0007940084],"domain_scores_gemma":[0.9917941,0.007251649,0.0002248328,0.0001574184,0.0001508111,0.0004211976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008019117,0.002852273,0.7451614,0.00128268,0.0003311116,0.001496813,0.002721652,0.00001126606,0.03687044,0.04372079,0.02192747,0.135605],"study_design_scores_gemma":[0.01237343,0.003084738,0.06647924,0.00002815956,0.000101794,0.00003840134,0.000184107,0.0001879065,0.0002600784,0.0005855513,0.9163662,0.000310419],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880404,0.0003008476,0.0002627775,0.003082986,0.003586159,0.001665581,0.00004974742,0.0001166621,0.002894774],"genre_scores_gemma":[0.9212451,0.001971782,0.00831329,0.06178334,0.0009124263,0.0006622538,0.00001983916,0.00004838964,0.005043606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8944387,"threshold_uncertainty_score":0.6101199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049816046","doi":"10.1097/00002826-200201000-00005","title":"A Double-Blind Crossover, Placebo-Controlled Study of the Adenosine A2A Antagonist Theophylline in Parkinson's Disease","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Theophylline; Crossover study; Antagonist; Placebo; Medicine; Adenosine; Double blind; Anesthesia; Pharmacology; Internal medicine; Pathology","authors":[{"name":"Jaime Kulisevsky","is_ca":true},{"name":"Manel J. Barbanoj","is_ca":false},{"name":"Alexandre Gironell","is_ca":true},{"name":"Rosa Antonijoan","is_ca":false},{"name":"Miguel Casas","is_ca":false},{"name":"Berta Pascual‐Sedano","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05653257955031033,"gpt":0.3572882097378645,"spread":0.3007556301875541,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004383747,0.0002470698,0.0005458399,0.000056884,0.0001082175,0.00001794095,0.0005662713,0.0001584663,0.0002431556],"category_scores_gemma":[0.0003968016,0.0001768114,0.0002836684,0.0002442059,0.0003042732,0.000005192579,0.0003393918,0.0004235373,0.00001447878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007467981,"about_ca_system_score_gemma":0.00005934683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001511128,"about_ca_topic_score_gemma":0.00001135276,"domain_scores_codex":[0.9971356,0.000764849,0.0009628367,0.0006102864,0.000185476,0.0003409444],"domain_scores_gemma":[0.998543,0.0003464696,0.0003354673,0.0005182953,0.00008683596,0.0001699526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4300059,0.02224407,0.4154112,0.0000883508,0.0007980834,0.000893274,0.0002827589,0.00437121,0.08321408,0.0001034728,0.04162463,0.0009628993],"study_design_scores_gemma":[0.7407561,0.006892849,0.1344079,0.0000436288,0.001005494,0.00004684579,0.0001627407,0.004426963,0.01119981,0.00008600828,0.09987011,0.001101569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948335,0.00181947,0.000006570435,0.000813963,0.0009017464,0.00133864,0.00001349794,0.00001180781,0.0002608239],"genre_scores_gemma":[0.9957277,0.0005893266,0.000009585907,0.001644766,0.0007303516,0.0001086168,0.000007230059,0.00003335275,0.001149109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3107502,"threshold_uncertainty_score":0.7210158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028210993","doi":"10.1097/wnf.0b013e3181ac155b","title":"Milnacipran","year":2009,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McGill University","keywords":"Milnacipran; Fibromyalgia; Antidepressant; Reuptake inhibitor; Pharmacology; Venlafaxine; Duloxetine; Tolerability; Psychology; Medicine; Internal medicine; Psychiatry; Anxiety; Adverse effect","authors":[{"name":"Chi‐Un Pae","is_ca":false},{"name":"David M. Marks","is_ca":false},{"name":"Manan Shah","is_ca":false},{"name":"Byung‐Joo Ham","is_ca":false},{"name":"Ashwin A. Patkar","is_ca":false},{"name":"Prakash S. Masand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2960391119950188,"gpt":0.5823993394174389,"spread":0.2863602274224202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003194224,0.0005602569,0.003796364,0.0002023845,0.00005402402,0.00001004727,0.0003173636,0.0008714118,0.0008400041],"category_scores_gemma":[0.00069623,0.0003875335,0.001651727,0.0002493921,0.0002148937,0.0000291066,0.0001533175,0.00179872,0.002806278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005528869,"about_ca_system_score_gemma":0.0003926984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.098966e-7,"about_ca_topic_score_gemma":6.378531e-8,"domain_scores_codex":[0.9957017,0.001084531,0.00156242,0.0009765182,0.0002278631,0.0004469512],"domain_scores_gemma":[0.9962668,0.002004377,0.0004791724,0.0006665722,0.00005733978,0.0005257606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001356816,0.001154363,0.00003492487,0.001771324,0.000245107,0.003159992,6.653069e-7,1.261178e-8,0.000001972247,0.000005314846,0.03023065,0.96326],"study_design_scores_gemma":[0.002935985,0.002069271,0.0004103333,0.00209745,0.0038812,0.0006879986,1.200289e-7,9.369297e-7,0.000001421437,0.00000743914,0.9876658,0.0002420121],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001550391,0.992134,5.974467e-7,0.0003693269,0.002428454,0.001597104,0.00001345137,0.0002505183,0.003051513],"genre_scores_gemma":[0.000008456893,0.9912674,0.0001992751,0.003667077,0.001774762,0.00007115452,0.00009263549,0.0001040285,0.002815188],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.963018,"threshold_uncertainty_score":0.9998577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005346374","doi":"10.1097/00002826-200007000-00003","title":"Mexiletine in the Treatment of Torticollis and Generalized Dystonia","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Spasmodic Torticollis; Mexiletine; Dystonia; Medicine; Anesthesia; Torticollis; Rating scale; Trihexyphenidyl; Adverse effect; Psychology; Internal medicine; Surgery; Psychiatry","authors":[{"name":"Claudio Lucetti","is_ca":false},{"name":"Angelo Nuti","is_ca":false},{"name":"Gianna Gambaccini","is_ca":false},{"name":"Silvia Bernardini","is_ca":false},{"name":"Stefania Brotini","is_ca":false},{"name":"Maria Laura Manca","is_ca":false},{"name":"Ubaldo Bonuccelli","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05272901068265193,"gpt":0.395296412991609,"spread":0.342567402308957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001678115,0.0001171915,0.0004250766,0.00003272731,0.00002768627,0.00000280284,0.00007881401,0.0001517787,0.001386846],"category_scores_gemma":[0.0000787386,0.00006326278,0.0001285495,0.0001601088,0.0003815671,0.00001035616,0.000009566284,0.0002512719,0.00003633497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006001394,"about_ca_system_score_gemma":0.00002111483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000012329,"about_ca_topic_score_gemma":0.000002517173,"domain_scores_codex":[0.9983907,0.0005171266,0.0005474116,0.000271549,0.00008417669,0.0001890866],"domain_scores_gemma":[0.9988279,0.0008384545,0.00005676129,0.0001628684,0.00001574461,0.00009821215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02444895,0.03298886,0.3380188,0.0001319003,0.000662083,0.009070079,0.001185852,0.0002463722,0.05310247,0.0007272877,0.009645522,0.5297718],"study_design_scores_gemma":[0.0168673,0.01263325,0.7881312,0.00000771067,0.0003937542,0.0001989359,0.00001042849,0.001014546,0.0005482247,0.0001746665,0.1798934,0.0001266447],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869519,0.000575081,2.962692e-7,0.01044987,0.0001749684,0.0004585388,0.000002599053,0.00001941125,0.001367304],"genre_scores_gemma":[0.960528,0.02692422,0.00005916498,0.01178562,0.00009821646,0.00002431333,0.000002546685,0.00001003023,0.0005678535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5296451,"threshold_uncertainty_score":0.999526,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084409189","doi":"10.1097/00002826-200005000-00003","title":"The Relationship between COMT Genotype and the Clinical Effectiveness of Tolcapone, a COMT Inhibitor, in Patients with Parkinson's Disease","year":2000,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Catechol-O-methyl transferase; Genotype; Levodopa; Internal medicine; Parkinson's disease; Clinical trial; Gastroenterology; Medicine; Psychology; Disease; Biology; Genetics; Gene","authors":[{"name":"Derek J. Chong","is_ca":true},{"name":"Oksana Suchowersky","is_ca":true},{"name":"Carol L. Szumlanski","is_ca":false},{"name":"Richard M. Weinshilboum","is_ca":false},{"name":"Norm R.C. Campbell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04146685183536344,"gpt":0.3644804545033011,"spread":0.3230136026679377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001605436,0.0002016577,0.0006990118,0.00004421838,0.0001751751,0.00001249409,0.0001641576,0.0001262896,0.00004613877],"category_scores_gemma":[0.001361179,0.0001062377,0.0001795139,0.0002165455,0.001154509,0.00004429176,0.0000797209,0.0006186056,0.00002984805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002251549,"about_ca_system_score_gemma":0.0001667789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001086017,"about_ca_topic_score_gemma":0.000003437762,"domain_scores_codex":[0.9949062,0.003267071,0.000833741,0.0004705005,0.000240065,0.0002824269],"domain_scores_gemma":[0.9813944,0.01758185,0.0002018936,0.0003708814,0.00008826955,0.0003626637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03499607,0.00111283,0.9528468,0.00004372588,0.000155011,0.0000919247,0.000008802976,0.000002774123,0.000001331671,0.0002521599,0.00007818952,0.01041037],"study_design_scores_gemma":[0.03193163,0.001433346,0.9597619,0.00006431701,0.0006516802,0.000001582603,0.000002050593,0.00005016616,0.000005083155,0.0005695724,0.005434099,0.00009461313],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969326,0.0003819655,0.000004047922,0.000776974,0.0003014415,0.001433196,0.00003574456,0.00002244823,0.0001116237],"genre_scores_gemma":[0.9984923,0.0003925038,0.00003007268,0.0007477194,0.0001490824,0.00007715882,0.00002698232,0.00002747164,0.00005669726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01431478,"threshold_uncertainty_score":0.4332249,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977455030","doi":"10.1097/01.wnf.0000220817.94102.95","title":"The Controversy Concerning Plasma Homocysteine in Parkinson Disease Patients Treated with Levodopa Alone or with Entacapone","year":2006,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Entacapone; Levodopa; Catechol-O-methyl transferase; Parkinson's disease; Homocysteine; Hyperhomocysteinemia; Concomitant; Medicine; Plasma homocysteine; Internal medicine; Pharmacology; Endocrinology; Psychology; Disease; Chemistry; Biochemistry; Genotype","authors":[{"name":"Theresa A. Zesiewicz","is_ca":true},{"name":"Lynn Wecker","is_ca":false},{"name":"Kelly L. Sullivan","is_ca":true},{"name":"Lisa R. Merlin","is_ca":false},{"name":"Robert A. Hauser","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09628879543517495,"gpt":0.4267736520732911,"spread":0.3304848566381162,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005558422,0.0006620184,0.002930566,0.0002281028,0.0001744712,0.00004487546,0.0004255008,0.0003372895,0.0001512332],"category_scores_gemma":[0.000890658,0.0003075242,0.0003625299,0.0007322183,0.0009162861,0.00006524243,0.0001735595,0.002162496,0.0001327419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001927689,"about_ca_system_score_gemma":0.001021907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000624822,"about_ca_topic_score_gemma":0.0001018442,"domain_scores_codex":[0.9940247,0.001804032,0.001658381,0.001045977,0.0005780327,0.0008888723],"domain_scores_gemma":[0.9915003,0.006478148,0.0006358693,0.0005565888,0.0002227572,0.0006063775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05927907,0.004554728,0.1021247,0.006621979,0.001737138,0.03960659,0.00001058114,0.000009261797,0.000004694099,0.000006468028,0.01195878,0.7740861],"study_design_scores_gemma":[0.02006364,0.007531707,0.01273947,0.002521512,0.002655686,0.000104739,0.000003406374,0.0001240973,0.000001660123,1.864837e-7,0.9538998,0.0003541229],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2643549,0.7287418,8.978929e-7,0.0004306635,0.0004846103,0.005301624,0.0001713352,0.0001035942,0.0004106633],"genre_scores_gemma":[0.01973663,0.9741244,0.00001579872,0.0005950257,0.0005075251,0.0003612704,0.0003970744,0.0001554943,0.004106816],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.941941,"threshold_uncertainty_score":0.9999377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032852860","doi":"10.1097/00002826-200207000-00005","title":"Cognitive Deficits and Striatal Dopaminergic Denervation in Parkinson's Disease: A Single Photon Emission Computed Tomography Study Using 123Iodine-β-CIT in Patients ON and OFF Levodopa","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital","funders":"","keywords":"Dopaminergic; Parkinson's disease; Levodopa; Cognition; Denervation; Psychology; Neuroscience; Executive functions; Single-photon emission computed tomography; Audiology; Medicine; Internal medicine; Disease; Dopamine","authors":[{"name":"Nicole Duchesne","is_ca":false},{"name":"Jean‐Paul Soucy","is_ca":true},{"name":"Hélène Masson","is_ca":true},{"name":"Sylvain Chouinard","is_ca":true},{"name":"Marc‐André Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0769197879628581,"gpt":0.3460114822832213,"spread":0.2690916943203632,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001865061,0.0002716869,0.0005420703,0.0003631581,0.00007268172,0.00001934264,0.00005619707,0.0001044804,0.00003995035],"category_scores_gemma":[0.0003251452,0.0002464833,0.00007455911,0.0004195476,0.0001089381,0.00008575923,0.000101785,0.0003296921,0.000004641768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005308188,"about_ca_system_score_gemma":0.00002494307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001924063,"about_ca_topic_score_gemma":0.000006849883,"domain_scores_codex":[0.9975559,0.0005335834,0.0006058416,0.0007616219,0.0002282817,0.0003148468],"domain_scores_gemma":[0.998669,0.0005510144,0.0001755745,0.0001285532,0.0000735272,0.0004022958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00385182,0.01138029,0.9684226,0.00003287704,0.0000617782,0.001056566,0.00005412272,0.000008209735,0.0005897688,0.000001507334,0.00002557861,0.01451492],"study_design_scores_gemma":[0.02631747,0.004085451,0.9594182,0.0001425628,0.0003146105,0.000005111846,0.00003090415,0.009150835,0.0001423759,0.00001221584,0.0002015525,0.0001787201],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977391,0.0004535137,0.00000245241,0.00007693927,0.0002752613,0.001347312,0.00004533654,0.0000334007,0.00002671266],"genre_scores_gemma":[0.9987406,0.0002341983,0.00004033729,0.0008062267,0.00006044173,0.00003621743,0.00003909673,0.00002942592,0.00001341929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02246565,"threshold_uncertainty_score":0.9999987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087320487","doi":"10.1097/00002826-200203000-00002","title":"Treatment of Patients With Tardive Dystonia With Olanzapine","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Spasmodic Torticollis; Cervical dystonia; Dystonia; Olanzapine; Torticollis; Rating scale; Visual analogue scale; Anesthesia; Psychology; Medicine; Schizophrenia (object-oriented programming); Surgery; Psychiatry","authors":[{"name":"Claudio Lucetti","is_ca":false},{"name":"Giovanna R. Bellini","is_ca":false},{"name":"Angelo Nuti","is_ca":false},{"name":"Silvia Bernardini","is_ca":false},{"name":"Grazia Dell’Agnello","is_ca":false},{"name":"Armando Piccinni","is_ca":false},{"name":"Luca Maggi","is_ca":false},{"name":"Maria Laura Manca","is_ca":false},{"name":"Ubaldo Bonuccelli","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04268668397250507,"gpt":0.3233205935032119,"spread":0.2806339095307068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003263625,0.0002034745,0.0006165282,0.00005339514,0.00004084905,0.000002384225,0.00008174537,0.0001704108,0.001278781],"category_scores_gemma":[0.00005808027,0.0001066442,0.0001358787,0.0001975709,0.0005523412,0.00002357747,0.00002353628,0.0003221625,0.0001315409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001357677,"about_ca_system_score_gemma":0.00002102018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001793801,"about_ca_topic_score_gemma":5.914435e-7,"domain_scores_codex":[0.9984919,0.0001915237,0.0004571941,0.000418166,0.0001682301,0.0002729566],"domain_scores_gemma":[0.9988372,0.0004129321,0.0001607046,0.0002276932,0.0001149886,0.0002465084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01457653,0.01567301,0.9352399,0.00005205656,0.0008830607,0.002091205,0.00007345063,0.00005736203,0.000853711,0.00004345254,0.002321846,0.02813449],"study_design_scores_gemma":[0.03385649,0.06333369,0.8667337,0.00001273989,0.0008425883,0.00006648344,0.000004013682,0.0004493294,0.0002789962,0.000008259654,0.03422411,0.0001895939],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947237,0.0001827584,0.000007655743,0.002434248,0.0002475115,0.0006204596,0.00001202574,0.00006439414,0.001707181],"genre_scores_gemma":[0.9942474,0.00144843,0.0001959583,0.003288603,0.00008015701,0.00001760233,0.00001127035,0.00002861151,0.0006819867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06850611,"threshold_uncertainty_score":0.9996342,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039473736","doi":"10.1097/00002826-200403000-00009","title":"Antidepressants in the Treatment of Psychosis With Comorbid Depression in Parkinson Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Psychosis; Psychiatry; Comorbidity; Depression (economics); Exacerbation; Parkinson's disease; Psychotic depression; Antidepressant; Disease; Depressive symptoms; Medicine; Psychology; Anxiety; Internal medicine","authors":[{"name":"Valerie Voon","is_ca":true},{"name":"Anthony E. Lang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05626604801569,"gpt":0.3955811821773232,"spread":0.3393151341616332,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001457643,0.0001875128,0.000477958,0.0001131676,0.0000302094,0.000004524397,0.0001308315,0.00007179687,0.00005283419],"category_scores_gemma":[0.0000529979,0.0001070438,0.0001370765,0.0002516889,0.0001506414,0.00003615442,0.00001861325,0.0001770485,0.00001698329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004957864,"about_ca_system_score_gemma":0.00009293285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006846734,"about_ca_topic_score_gemma":0.00003500536,"domain_scores_codex":[0.9982633,0.0003269948,0.0004906419,0.0004605521,0.0001889976,0.0002695423],"domain_scores_gemma":[0.9989476,0.0003409691,0.0001257836,0.000338976,0.00002583429,0.0002207942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005667537,0.01314823,0.9673825,0.00002429626,0.00006319102,0.005097032,0.00007379126,0.0000795726,0.0005107441,0.00001658517,0.00004666021,0.007889894],"study_design_scores_gemma":[0.02064956,0.002655277,0.9674488,0.00007849555,0.0002716571,0.00002298093,0.00001388939,0.0000678332,0.0009507654,0.000112614,0.007643145,0.00008493025],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969354,0.0007763281,0.000009320815,0.001003788,0.0002256526,0.0008586716,0.000018754,0.00001781256,0.0001542841],"genre_scores_gemma":[0.9941759,0.003857805,0.0001394838,0.001559336,0.0000714585,0.0001504869,0.00001207395,0.00002031059,0.00001319427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01498202,"threshold_uncertainty_score":0.436512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1824305151","doi":"10.1097/wnf.0b013e318059be76","title":"Add-on Therapy With Acetylcholinesterase Inhibitors for Memory Dysfunction in Schizophrenia","year":2007,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Donepezil; Rivastigmine; Neurocognitive; Schizophrenia (object-oriented programming); Galantamine; Randomized controlled trial; Placebo; Memory impairment; Psychology; Medicine; Verbal memory; Meta-analysis; Clinical trial; Cognition; Dementia; Psychiatry; Internal medicine","authors":[{"name":"Émmanuel Stip","is_ca":true},{"name":"Amir A. Sepehry","is_ca":true},{"name":"Sylvie Chouinard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.205014524744987,"gpt":0.4969339128382372,"spread":0.2919193880932501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001009905,0.0007155708,0.00281022,0.0007318208,0.00008234284,0.00002197732,0.0002496393,0.0007104515,0.0002012479],"category_scores_gemma":[0.0006315543,0.000452364,0.0009134421,0.0006544265,0.0003166654,0.00005228204,0.00007143586,0.002185621,0.0002510905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001949961,"about_ca_system_score_gemma":0.001198976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004384842,"about_ca_topic_score_gemma":0.0000191849,"domain_scores_codex":[0.9952108,0.0007959284,0.001601456,0.001245468,0.0003754687,0.0007708257],"domain_scores_gemma":[0.9932404,0.004976464,0.0004209898,0.0005816486,0.0001619546,0.0006185353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.06870836,0.002020722,0.00008631773,0.001713641,0.0004202771,0.001867434,0.000002969457,8.754427e-7,0.000004555927,0.00001587566,0.002539744,0.9226192],"study_design_scores_gemma":[0.04915553,0.01118527,0.0006605237,0.002766821,0.00105273,0.0003357111,0.000002833228,0.000009388729,0.00003778994,0.0000113291,0.934354,0.0004280798],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0461607,0.9436309,0.000008519192,0.0004282095,0.002250762,0.007182771,0.00006155256,0.0001308928,0.0001457303],"genre_scores_gemma":[0.0004573284,0.9922305,0.0005677602,0.002064383,0.002853809,0.001028763,0.0002227186,0.0001804865,0.000394225],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9318143,"threshold_uncertainty_score":0.9997928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054808759","doi":"10.1097/00002826-200305000-00005","title":"Medications and Substances as a Cause of Headache: A Systematic Review of the Literature","year":2003,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Etiology; Medicine; Intensive care medicine; Headaches; Identification (biology); Psychiatry; Biology","authors":[{"name":"Cory Toth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1112457628367054,"gpt":0.501474342080962,"spread":0.3902285792442566,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001127273,0.0002958137,0.004935969,0.00007930714,0.00004748625,0.000002567036,0.0002549866,0.0002775353,0.00009381132],"category_scores_gemma":[0.005134082,0.0001512306,0.0009622552,0.0006147833,0.0006599568,0.00001487071,0.000115986,0.0009833573,0.000009635306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001306854,"about_ca_system_score_gemma":0.000516703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000012864,"about_ca_topic_score_gemma":0.000001676487,"domain_scores_codex":[0.9947581,0.002003645,0.00243924,0.0003737206,0.0002461951,0.0001791103],"domain_scores_gemma":[0.9943619,0.003250164,0.001382603,0.0005931502,0.0002709491,0.0001412501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000008269054,0.0001690747,0.00002740121,0.9817955,0.0008583415,0.00004400938,0.00004717525,6.568833e-10,8.081232e-7,0.0001750799,0.01567261,0.001201749],"study_design_scores_gemma":[0.0003198324,0.0002435854,0.00002387959,0.5839449,0.01935637,0.0004055292,0.00000767108,1.425701e-7,5.264141e-7,0.00001182698,0.3956037,0.00008207568],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008113375,0.9950926,1.964184e-7,0.001216117,0.0001765092,0.002885149,0.00003911008,0.00001008161,0.0004991585],"genre_scores_gemma":[0.00002616566,0.9926688,0.00002311541,0.005062568,0.0001171649,0.0001837771,0.00001120245,0.00002633314,0.001880841],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3978506,"threshold_uncertainty_score":0.6167004,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2399313480","doi":"10.1097/wnf.0000000000000102","title":"Caffeine and Progression of Parkinson Disease","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Coffee research and impacts","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke","keywords":"Caffeine; Medicine; Parkinson's disease; Disease; Neuroscience; Psychology; Internal medicine","authors":[{"name":"David K. Simon","is_ca":false},{"name":"Cai Wu","is_ca":false},{"name":"Barbara C. Tilley","is_ca":false},{"name":"Anne‐Marie Wills","is_ca":false},{"name":"Michael J. Aminoff","is_ca":false},{"name":"Jacquelyn Bainbridge","is_ca":false},{"name":"Robert A. Hauser","is_ca":false},{"name":"Jay S. Schneider","is_ca":false},{"name":"Saloni Sharma","is_ca":false},{"name":"Carlos Singer","is_ca":false},{"name":"Caroline M. Tanner","is_ca":false},{"name":"Daniel Truong","is_ca":false},{"name":"Pei Shieen Wong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1888840536484773,"gpt":0.5239963377592634,"spread":0.3351122841107861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004344521,0.00007631171,0.0002897138,0.00005604121,0.0000154589,0.000003398068,0.00005629576,0.00005114753,0.00008238589],"category_scores_gemma":[0.003426282,0.00005517934,0.00005977976,0.00009984992,0.0003227582,0.00003268272,0.0001154991,0.0002593389,0.00002464263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009135767,"about_ca_system_score_gemma":0.000264381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002328804,"about_ca_topic_score_gemma":2.910526e-7,"domain_scores_codex":[0.9988164,0.0002699747,0.0003073543,0.0002131116,0.0001809633,0.0002122461],"domain_scores_gemma":[0.9978614,0.0004519548,0.00006780098,0.0001443518,0.0001231139,0.001351389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01259085,0.00166753,0.7683627,0.0002181495,0.00006635083,0.001781798,0.00003219444,9.062356e-7,0.01895976,0.00003891234,0.04394636,0.1523345],"study_design_scores_gemma":[0.006349027,0.005110375,0.879698,0.000039307,0.0001171174,0.00004420751,0.000005346993,0.0006930893,0.001259374,0.00007894022,0.1065381,0.00006711359],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930319,0.001009781,0.000004274497,0.004882926,0.0003073349,0.0003199192,0.000004589948,0.00002591219,0.0004133961],"genre_scores_gemma":[0.9970512,0.0008888164,0.0001201579,0.001410706,0.0002852247,0.000007116038,0.000004166252,0.00001156064,0.0002210444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1522674,"threshold_uncertainty_score":0.4101827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002651101","doi":"10.1097/wnf.0b013e318263163c","title":"Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia","year":2012,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cervical dystonia; Immunogenicity; Medicine; Botulinum toxin; Seroconversion; Adverse effect; Internal medicine; Clinical trial; Botulism; Spasmodic Torticollis; Antibody; Immunology; Surgery; Torticollis; Biology","authors":[{"name":"Robert Chinnapongse","is_ca":false},{"name":"Mark Lew","is_ca":false},{"name":"Joaquim J. Ferreira","is_ca":false},{"name":"Kristen Gullo","is_ca":false},{"name":"Paul R. Nemeth","is_ca":false},{"name":"Yuxin Zhang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07284874114159376,"gpt":0.4068194709946589,"spread":0.3339707298530652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003423422,0.0001624741,0.0006121905,0.00005476315,0.00002685782,0.000001955898,0.0001456645,0.0002727184,0.0002135856],"category_scores_gemma":[0.0002757414,0.00009389492,0.0002034728,0.0002465206,0.0006026325,0.00002393574,0.00005176584,0.0004472255,0.00002328059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001083682,"about_ca_system_score_gemma":0.00003700285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005316287,"about_ca_topic_score_gemma":0.000001733862,"domain_scores_codex":[0.997852,0.000677647,0.0007746262,0.0002557788,0.0001255469,0.0003144165],"domain_scores_gemma":[0.997346,0.002041653,0.0001585294,0.0002552102,0.00004123074,0.00015737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005491384,0.01239851,0.9388521,0.00006832629,0.0001893195,0.0002219185,0.0003172404,0.000004052826,0.03035893,0.0000981082,0.0001162054,0.01188395],"study_design_scores_gemma":[0.007106402,0.006229523,0.9837129,0.00000973687,0.0003189156,0.00008638786,0.000009839233,0.00003832262,0.001402356,0.00001426347,0.0009987118,0.00007261274],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994341,0.002505029,0.000001486254,0.001796708,0.0006213716,0.0005416152,0.000003229325,0.00001623224,0.0001734012],"genre_scores_gemma":[0.9886231,0.008897773,0.00002911667,0.002239907,0.0001420578,0.000007447779,0.000004334722,0.0000140764,0.00004220278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04486087,"threshold_uncertainty_score":0.3828923,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2332272503","doi":"10.1097/wnf.0b013e3181f5a5f9","title":"Bupropion for Depression in Schizophrenia","year":2010,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bupropion; Positive and Negative Syndrome Scale; Psychiatry; Psychology; Extrapyramidal symptoms; Tolerability; Schizophrenia (object-oriented programming); Antidepressant; Antipsychotic; Major depressive disorder; Medicine; Psychosis; Internal medicine; Adverse effect; Mood","authors":[{"name":"Susanne Englisch","is_ca":false},{"name":"Dragoš Inta","is_ca":false},{"name":"Andrea Eer","is_ca":false},{"name":"Mathias Zink","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05490505063828417,"gpt":0.4442350276429075,"spread":0.3893299770046233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003912124,0.0001238399,0.0003536803,0.0001256027,0.00005233164,0.000008079283,0.0001250011,0.0001912521,0.0002878117],"category_scores_gemma":[0.001479785,0.00009813373,0.0001690365,0.0001409197,0.0001661994,0.00003740215,0.00007859779,0.0009235243,0.0001432279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001462593,"about_ca_system_score_gemma":0.0002087758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005168916,"about_ca_topic_score_gemma":0.00003638765,"domain_scores_codex":[0.9984741,0.0001336917,0.0004548894,0.0004514216,0.0001276252,0.0003582369],"domain_scores_gemma":[0.9980214,0.001228295,0.00006167859,0.0002556676,0.00008234379,0.0003506143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08502705,0.002755279,0.4154685,0.00007224073,0.00008338234,0.001167766,0.00000886996,0.000001383161,0.1944769,0.0008630272,0.00352072,0.2965549],"study_design_scores_gemma":[0.03014178,0.001565806,0.9514237,0.00001325005,0.00007513441,0.00009178639,0.00000174296,0.0009604106,0.007668259,0.0008015715,0.007149363,0.0001072037],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941772,0.00006635312,0.00002099284,0.002888137,0.001567806,0.001020761,0.000006555713,0.00005888374,0.0001932815],"genre_scores_gemma":[0.992029,0.0001267193,0.00533784,0.001329025,0.0007826697,0.0001934917,0.00001616767,0.0000265773,0.0001585217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5359552,"threshold_uncertainty_score":0.4012305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970671532","doi":"10.1097/00002826-200309000-00004","title":"Poor Tolerability of a Transdermal Nicotine Treatment in Parkinson's Disease","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôtel-Dieu de Montréal; Hôtel-Dieu de Québec; Université du Québec à Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tolerability; Transdermal; Medicine; Nicotine; Nausea; Vomiting; Adverse effect; Anesthesia; Parkinson's disease; Pharmacology; Internal medicine; Disease","authors":[{"name":"Simon Lemay","is_ca":true},{"name":"Pierre J. Blanchet","is_ca":false},{"name":"Sylvain Chouinard","is_ca":false},{"name":"Hélène Masson","is_ca":false},{"name":"Valérie Soland","is_ca":false},{"name":"Marc‐André Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03115746267772081,"gpt":0.3604565407004209,"spread":0.3292990780227001,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004810345,0.0002245061,0.0004888793,0.00004237593,0.00002901046,0.000003260539,0.0002109334,0.0001579394,0.0002004879],"category_scores_gemma":[0.0008109555,0.0002031808,0.000296816,0.0001362801,0.0002907901,0.000003007752,0.00006187346,0.0002113998,0.00001521723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002020283,"about_ca_system_score_gemma":0.0002579183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008253185,"about_ca_topic_score_gemma":0.00002201408,"domain_scores_codex":[0.9968345,0.001162305,0.0008760929,0.0006713973,0.00009786889,0.0003578828],"domain_scores_gemma":[0.9988896,0.0002539975,0.000161241,0.0003752321,0.00005976513,0.000260222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001943178,0.006114173,0.7965845,0.0000364483,0.0001223058,0.00002199999,0.00002919242,0.0001462708,0.1889193,0.00006496462,0.001015882,0.005001778],"study_design_scores_gemma":[0.01489578,0.0044127,0.2119393,0.000009857089,0.0002086829,0.00001779303,0.00002686891,0.0001677676,0.2514599,0.00004891761,0.516302,0.0005104579],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973773,0.0004670719,0.00003779271,0.0004625205,0.0006924254,0.000550985,0.00002692044,0.00001255836,0.0003723621],"genre_scores_gemma":[0.9974546,0.0008599519,0.0002188009,0.000949974,0.0001902548,0.00006244132,0.00001742656,0.00002807685,0.0002184817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5846453,"threshold_uncertainty_score":0.8285474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1923911528","doi":"10.1097/wnf.0000000000000101","title":"A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Allergan; Ipsen","keywords":"Medicine; Cervical dystonia; Confidence interval; Spasmodic Torticollis; Randomized controlled trial; Anesthesia; Botulinum toxin; Significant difference; Crossover study; Surgery; Torticollis; Internal medicine","authors":[{"name":"Alma Rystedt","is_ca":false},{"name":"Lena Zetterberg","is_ca":false},{"name":"Joachim Burman","is_ca":false},{"name":"Dag Nyholm","is_ca":false},{"name":"Anders Johansson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2577468131499699,"gpt":0.4951198360469998,"spread":0.2373730228970299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004843052,0.0002136486,0.0009056989,0.00009781255,0.00006573535,0.000006687289,0.0001373146,0.000439135,0.0003216262],"category_scores_gemma":[0.000715649,0.0001699377,0.0001697469,0.0002460648,0.0008252959,0.00005618643,0.0001742345,0.0009791838,0.00006517799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001838504,"about_ca_system_score_gemma":0.0001855842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001069974,"about_ca_topic_score_gemma":5.866742e-7,"domain_scores_codex":[0.9973868,0.000501834,0.00102694,0.0005267494,0.000230424,0.0003272272],"domain_scores_gemma":[0.9979781,0.0007593515,0.0003181845,0.0002248559,0.0001564767,0.0005630511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01410772,0.006748806,0.7544877,0.000283121,0.0004622689,0.002334098,0.0003783592,0.0004730515,0.1766579,0.0001970227,0.0354744,0.008395516],"study_design_scores_gemma":[0.07242793,0.03468389,0.6040995,0.0001502756,0.003616119,0.000910597,0.0005196109,0.1542323,0.01790951,0.0005631587,0.1095695,0.001317553],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993999,0.0005167945,0.00004781416,0.00259304,0.001376281,0.0005268365,0.000003936273,0.00007906358,0.0008572385],"genre_scores_gemma":[0.9914253,0.0006442618,0.0002431599,0.007190408,0.0001775472,0.000004345766,0.000008502098,0.00002872529,0.0002777161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1587484,"threshold_uncertainty_score":0.692986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095110740","doi":"10.1097/wnf.0b013e31802fa61a","title":"Oral Cholinesterase Inhibitor Add-on Therapy for Cognitive Enhancement in Schizophrenia","year":2007,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Louis-H Lafontaine; Université du Québec à Montréal","funders":"","keywords":"Neurocognitive; Schizophrenia (object-oriented programming); Cognition; Psychology; Executive functions; Physical medicine and rehabilitation; Medicine; Psychiatry","authors":[{"name":"Sylvie Chouinard","is_ca":true},{"name":"Amir A. Sepehry","is_ca":true},{"name":"Émmanuel Stip","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2847984843581851,"gpt":0.5543568871014394,"spread":0.2695584027432543,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00115865,0.0007615883,0.003326319,0.0006363607,0.00007794999,0.00002413467,0.0002762406,0.0006787311,0.0005643726],"category_scores_gemma":[0.001422722,0.0005444853,0.001248792,0.0005203636,0.0003308753,0.00004078253,0.0001251538,0.002049742,0.0005680771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001886075,"about_ca_system_score_gemma":0.001234953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002970677,"about_ca_topic_score_gemma":0.00001022621,"domain_scores_codex":[0.994276,0.001012472,0.00203153,0.00136033,0.0003806711,0.000938923],"domain_scores_gemma":[0.9905903,0.007647701,0.0004294281,0.0004096508,0.0002226381,0.0007003253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05920276,0.004097532,0.00007185071,0.001547756,0.0005290659,0.002211836,0.000003799426,3.735365e-8,0.000004931926,0.00002429867,0.00137143,0.9309347],"study_design_scores_gemma":[0.05843266,0.01423961,0.000858682,0.004459121,0.001227087,0.0001131983,0.000002499405,0.00001030734,0.00009880275,0.00003185546,0.9200311,0.0004950606],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03967871,0.9481706,0.0000139637,0.0002813875,0.002340156,0.009124558,0.0001869376,0.00007531587,0.0001283836],"genre_scores_gemma":[0.001122352,0.9894961,0.0004844839,0.003559719,0.002539799,0.001804107,0.0004481272,0.0001485063,0.0003967805],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9304397,"threshold_uncertainty_score":0.9997007,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045278212","doi":"10.1097/00002826-200403000-00004","title":"Dopaminergic Properties and Experimental Anti-Parkinsonian Effects of IPX750 in Rodent Models of Parkinson Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Dopaminergic; Dopamine transporter; Dopamine; Pharmacology; Chemistry; Dopamine Plasma Membrane Transport Proteins; Agonist; Biochemistry; Biology; Receptor; Neuroscience","authors":[{"name":"Chuantao Jiang","is_ca":false},{"name":"Xinhua Wan","is_ca":false},{"name":"Joseph Jankovic","is_ca":false},{"name":"Samuel T. Christian","is_ca":false},{"name":"Zdenek B. Pristupa","is_ca":true},{"name":"Hyman B. Niznik","is_ca":true},{"name":"John S. Sundsmo","is_ca":false},{"name":"Weidong Le","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0680360821334167,"gpt":0.3304043789368377,"spread":0.262368296803421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001687161,0.000153445,0.0004367216,0.00009931341,0.00003927945,0.000008628261,0.0002145382,0.00006609964,0.00001888017],"category_scores_gemma":[0.0003554718,0.0001300977,0.0001010939,0.000157156,0.0005527986,0.0001126837,0.0001761187,0.000238306,0.00000461231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001650419,"about_ca_system_score_gemma":0.00005188409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002061513,"about_ca_topic_score_gemma":8.129046e-7,"domain_scores_codex":[0.9980381,0.0004407638,0.0006321267,0.0004786994,0.0001655111,0.0002448134],"domain_scores_gemma":[0.9990422,0.000427572,0.0001784875,0.0001495282,0.00001888323,0.0001832905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005223589,0.001092995,0.004723056,0.0001080029,0.000004517558,0.0002223043,0.0001615054,0.003866828,0.9884211,0.0003807998,0.000009621859,0.0004869026],"study_design_scores_gemma":[0.003657629,0.0008213518,0.0194049,0.00009627514,0.00002649945,0.00000775609,0.00001520278,0.003509522,0.971775,0.0003109791,0.0002174726,0.0001574387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980214,0.0007204006,0.00001021082,0.0001638604,0.0006374009,0.0003660822,0.000002680977,0.00002239058,0.00005563844],"genre_scores_gemma":[0.9983239,0.0008601646,0.00004232682,0.0006623747,0.00005704441,0.0000154752,2.255134e-7,0.00002466691,0.00001384124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01664613,"threshold_uncertainty_score":0.5305232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068802937","doi":"10.1097/00002826-200601000-00010","title":"Somatic Augmentation Strategies in Clozapine Resistance-What Facts?","year":2006,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Clozapine; Polypharmacy; Tolerability; Medicine; Electroconvulsive therapy; Rotigotine; Clinical trial; Transcranial magnetic stimulation; Psychiatry; Psychology; Pharmacology; Adverse effect; Internal medicine; Stimulation; Disease; Schizophrenia (object-oriented programming)","authors":[{"name":"Constantin Tranulis","is_ca":true},{"name":"Fayçal Mouaffak","is_ca":false},{"name":"Laurent Chouchana","is_ca":false},{"name":"Émmanuel Stip","is_ca":true},{"name":"Raphaël Gourévitch","is_ca":false},{"name":"Marie Poirier","is_ca":false},{"name":"Jean‐Pierre Olié","is_ca":false},{"name":"Henri Lôo","is_ca":false},{"name":"David Gourion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1426187868477103,"gpt":0.5178340429518419,"spread":0.3752152561041315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004292422,0.0005891068,0.003631198,0.0003354499,0.00006504726,0.00004989612,0.0002670349,0.0004593725,0.0002109831],"category_scores_gemma":[0.0003102966,0.0004803902,0.0006535726,0.0005009566,0.0004076969,0.0001989786,0.00009998197,0.001596389,0.0002449458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00020648,"about_ca_system_score_gemma":0.0005992816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004899961,"about_ca_topic_score_gemma":0.0000431679,"domain_scores_codex":[0.994522,0.001461495,0.002358982,0.0008523195,0.000235638,0.0005695918],"domain_scores_gemma":[0.9957599,0.002835966,0.0007706753,0.0003801475,0.0001082149,0.0001451052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001099143,0.001211078,0.0001137581,0.02421229,0.0008549353,0.002177179,0.00004595852,0.00000127478,0.0001501365,0.0001253884,0.008997569,0.9610113],"study_design_scores_gemma":[0.005184311,0.0008790002,0.0006455272,0.00458669,0.001920585,0.00005997387,0.00003725897,0.00000230035,0.000008963683,0.0002226525,0.9860907,0.0003620861],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002758187,0.9919622,0.000007152348,0.0006277288,0.001502337,0.00240697,0.000007695676,0.0001088812,0.0006188545],"genre_scores_gemma":[0.0000859264,0.9951651,0.0001278672,0.001509824,0.0008219873,0.0003442253,0.0001224316,0.0001066687,0.001716011],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9770931,"threshold_uncertainty_score":0.9997648,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032203345","doi":"10.1097/wnf.0b013e3181f8d4ed","title":"Evidence for Use of Mood Stabilizers and Anticonvulsants in the Treatment of Nonaffective Disorders in Children and Adolescents","year":2010,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Hotel Dieu Hospital","funders":"","keywords":"Mood; Mood disorders; Lithium (medication); Psychiatry; Mood stabilizer; Divalproex; Anticonvulsant; Psychology; Bipolar disorder; Lamotrigine; Clinical psychology; Medicine; Mania; Anxiety; Epilepsy","authors":[{"name":"Alfred Amaladoss","is_ca":true},{"name":"Nasreen Roberts","is_ca":false},{"name":"Franklin Amaladoss","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1707224189536841,"gpt":0.4752191105979739,"spread":0.3044966916442898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004154344,0.0002759892,0.001289734,0.0001371343,0.00002974849,0.000007095351,0.0001902846,0.0002944107,0.00001526333],"category_scores_gemma":[0.0002077315,0.0001829682,0.0002683574,0.0001769646,0.0004772331,0.00003862189,0.00004363916,0.0004234624,0.000001746641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001660316,"about_ca_system_score_gemma":0.00007380499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004222296,"about_ca_topic_score_gemma":0.00008484958,"domain_scores_codex":[0.9970788,0.001025744,0.0009994298,0.0005644656,0.00008660183,0.0002449596],"domain_scores_gemma":[0.9955202,0.003827325,0.0003841909,0.0001757936,0.00002626961,0.00006622382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003522829,0.002861083,0.244294,0.001057591,0.0001044368,0.000002623731,0.0002210268,9.376168e-8,0.000002284296,0.00004237341,0.0000438828,0.7510183],"study_design_scores_gemma":[0.003151534,0.001092845,0.9607632,0.00242735,0.0003258417,0.00001086105,0.00001286205,0.000001763584,3.244423e-7,0.00005511345,0.03199429,0.0001640101],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.5654244,0.4307205,0.000001159644,0.0001060682,0.0009160078,0.002717778,0.0001012792,0.000003726957,0.00000901456],"genre_scores_gemma":[0.1275073,0.87213,0.00001999302,0.0001081124,0.0001042207,0.00008987365,0.00001351622,0.00001786623,0.000009021268],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.7508543,"threshold_uncertainty_score":0.7461227,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087720405","doi":"10.1097/wnf.0000000000000034","title":"Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth","year":2014,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders; University of Toronto","funders":"","keywords":"Levodopa; Small intestinal bacterial overgrowth; Bacterial overgrowth; Medicine; Parkinson's disease; Gastroenterology; Disease; Internal medicine","authors":[{"name":"Alfonso Fasano","is_ca":true},{"name":"Francesco Bove","is_ca":false},{"name":"Maurizio Gabrielli","is_ca":false},{"name":"Enzo Ragazzoni∘","is_ca":false},{"name":"Serena Fortuna","is_ca":false},{"name":"Annalisa Tortora","is_ca":false},{"name":"Maria Assunta Zocco","is_ca":false},{"name":"Stefano Marconi","is_ca":false},{"name":"Antonio Gasbarrini","is_ca":false},{"name":"Anna Rita Bentivoglio","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03021068418300843,"gpt":0.3101651354656374,"spread":0.279954451282629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004072963,0.000239805,0.0005372521,0.00009242058,0.0000514295,0.00001603056,0.0001209364,0.0000723113,0.0001961813],"category_scores_gemma":[0.004228441,0.0002015187,0.00008200415,0.0001392843,0.0004909973,0.00006681267,0.000131153,0.0006010172,0.00001723088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003417946,"about_ca_system_score_gemma":0.0001407895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000104447,"about_ca_topic_score_gemma":0.00002771007,"domain_scores_codex":[0.9977362,0.0004893509,0.0005694861,0.0006126693,0.0001887008,0.0004036655],"domain_scores_gemma":[0.9973834,0.001495724,0.0001390447,0.0002271752,0.0001365949,0.0006180305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2341837,0.0007939779,0.7620088,0.00005945039,0.00002425312,0.0001489275,0.000008403487,0.000004728588,0.0001431569,0.00003991051,0.0001557864,0.002428886],"study_design_scores_gemma":[0.02818478,0.03304593,0.9336959,0.00006871126,0.000208367,0.000008744561,0.000005062533,0.0001549885,0.00002304356,0.00003386491,0.004418041,0.000152585],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972182,0.00001678177,0.00006941539,0.001090028,0.0007824293,0.0004814898,0.00001496626,0.00005931044,0.000267364],"genre_scores_gemma":[0.9974052,0.00002897229,0.0007083834,0.001484658,0.0002803573,0.00001465629,0.00002832521,0.00003103681,0.00001842848],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2059989,"threshold_uncertainty_score":0.8217695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051115769","doi":"10.1097/00002826-200107000-00004","title":"Comparison of Two Dosages of Tolcapone Added to Levodopa in Nonfluctuating Patients with PD","year":2001,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital de l'Enfant-Jésus; Roche (Canada); University of Calgary; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Dose; Adverse effect; Levodopa; Nausea; Crossover study; Medicine; Dyskinesia; Tolerability; Anesthesia; Placebo; Internal medicine; Parkinson's disease; Disease","authors":[{"name":"Oksana Suchowersky","is_ca":true},{"name":"Peter Bailey","is_ca":true},{"name":"Emmanuelle Pourcher","is_ca":true},{"name":"Lynne Bulger","is_ca":true},{"name":"Giovanni Facciponte","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07501022924080697,"gpt":0.4547305578632965,"spread":0.3797203286224896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001808045,0.0001590842,0.0008152039,0.0001437041,0.00002096986,0.000001991482,0.0001144925,0.00006323701,0.0003062144],"category_scores_gemma":[0.000349734,0.0001260545,0.00009640941,0.0003145066,0.000108981,0.00003871001,0.00008001233,0.0002314916,0.00002781601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002116135,"about_ca_system_score_gemma":0.00006916288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002471138,"about_ca_topic_score_gemma":0.00001211751,"domain_scores_codex":[0.998071,0.0002317788,0.0008514365,0.0003661422,0.0002184964,0.0002611876],"domain_scores_gemma":[0.9985583,0.0005566974,0.0002737385,0.0002125666,0.0001466471,0.0002519793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004340985,0.004614595,0.9682436,0.00003734104,0.0001015675,0.0002465195,0.00006282496,0.00005350909,0.01090356,0.00001936538,0.0001360303,0.01124011],"study_design_scores_gemma":[0.01533168,0.00454759,0.9720168,0.00006690111,0.0002516853,0.00000456939,0.00001822799,0.0003185929,0.00644485,0.00001934803,0.0008805859,0.00009916587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998416,0.00005490864,0.00004949324,0.0002146132,0.0002663472,0.0006108549,0.00001843111,0.00001832814,0.0003510085],"genre_scores_gemma":[0.9977264,0.00003265055,0.00116247,0.0009049629,0.00006158286,0.00002235533,0.00001499796,0.00002263664,0.0000518952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01114095,"threshold_uncertainty_score":0.5140352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085470371","doi":"10.1097/00002826-200307000-00007","title":"Pharmacokinetic Studies of Single and Multiple Oral Doses of Fampridine-SR (Sustained-Release 4-Aminopyridine) in Patients With Chronic Spinal Cord Injury","year":2003,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Lawson Health Research Institute; Western University","funders":"","keywords":"Pharmacokinetics; 4-Aminopyridine; Medicine; Dosing; Spinal cord injury; Adverse effect; Anesthesia; Oral administration; Spinal cord; Pharmacology; Internal medicine","authors":[{"name":"Keith C. Hayes","is_ca":true},{"name":"Patrick J. Potter","is_ca":true},{"name":"Robert R. Hansebout","is_ca":true},{"name":"J Bugaresti","is_ca":true},{"name":"Jane Hsieh","is_ca":true},{"name":"Sera Nicosia","is_ca":true},{"name":"Mitchell A. Katz","is_ca":false},{"name":"Andrew R. Blight","is_ca":false},{"name":"Ron Cohen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1136157444778536,"gpt":0.4635978927958428,"spread":0.3499821483179892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005621157,0.0002823463,0.001082055,0.0003198339,0.00004009077,0.000004083029,0.0001738587,0.0001143556,0.0001260619],"category_scores_gemma":[0.003093854,0.0002264314,0.0001121132,0.0005767537,0.001305843,0.00007898244,0.0001864953,0.0006624729,0.000006485486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000985935,"about_ca_system_score_gemma":0.0002870463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001255678,"about_ca_topic_score_gemma":0.000005596537,"domain_scores_codex":[0.996841,0.0005725247,0.001139209,0.0005658228,0.0003754626,0.000505995],"domain_scores_gemma":[0.9974926,0.0009705061,0.0003415834,0.0002821305,0.0006387455,0.0002743948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0954061,0.003460059,0.7656461,0.0008414518,0.0002659363,0.0002504329,0.00001215111,0.00001065299,0.1140257,0.0000265933,0.0007090901,0.01934574],"study_design_scores_gemma":[0.03359269,0.1719382,0.7238819,0.0002217416,0.0005094587,0.00002482758,0.00007444334,0.0002287711,0.06650272,0.00002419792,0.00266993,0.0003311944],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970224,0.00117096,0.000004557426,0.0002489377,0.0003756818,0.001076697,0.00001714861,0.00002369839,0.00005994555],"genre_scores_gemma":[0.9979429,0.001013025,0.0002716957,0.0005369298,0.00009496947,0.00002206593,0.000005350032,0.00004336812,0.00006975602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1684781,"threshold_uncertainty_score":0.9233603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085751814","doi":"10.1097/01.wnf.0000220823.80640.44","title":"Topiramate-induced Psychosis in Patients with Essential Tremor","year":2006,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Topiramate; Paranoia; Psychosis; Psychiatry; Medicine; Essential tremor; Adverse effect; Psychology; Pediatrics; Epilepsy; Internal medicine","authors":[{"name":"Theresa Zesiewicz","is_ca":true},{"name":"Archer Tullidge","is_ca":false},{"name":"Jonathan Tidwell","is_ca":false},{"name":"Kelly L. Sullivan","is_ca":true},{"name":"Robert A. Hauser","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02673696237727847,"gpt":0.3604325734656091,"spread":0.3336956110883307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006944741,0.0001741432,0.0004447575,0.00007147741,0.0000353978,0.000007660049,0.00009005399,0.0001345151,0.0003781708],"category_scores_gemma":[0.00006848326,0.0001207668,0.0001145334,0.000198411,0.0001203769,0.00003442499,0.00003946694,0.000374872,0.0001135736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001381683,"about_ca_system_score_gemma":0.00002315966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003432295,"about_ca_topic_score_gemma":0.00001080242,"domain_scores_codex":[0.9983242,0.0001897139,0.0005139731,0.0005005143,0.0001479523,0.0003236919],"domain_scores_gemma":[0.9992878,0.000242277,0.00009557176,0.0001910517,0.0000519131,0.0001313683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002858208,0.005672582,0.9845078,0.0000102838,0.00003356411,0.0005390728,0.000001819878,0.000002721049,0.0005134815,0.00003314467,0.001659149,0.00416816],"study_design_scores_gemma":[0.01716575,0.003851575,0.9774305,0.000005915969,0.0001139778,0.000002507599,6.646542e-7,0.00002933411,0.0001732289,0.0001710207,0.0009515326,0.000103944],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951499,0.0000136192,0.000001917943,0.002009978,0.0005670033,0.000577411,0.000004100946,0.00005899839,0.001617103],"genre_scores_gemma":[0.9914571,0.00001865088,0.00006667005,0.008026519,0.0001703263,0.00002910099,0.00001878429,0.00002365569,0.0001891719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01430754,"threshold_uncertainty_score":0.4924728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3013161772","doi":"10.1097/wnf.0000000000000384","title":"Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series","year":2020,"lang":"en","type":"review","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Venlafaxine; Mirtazapine; Mianserin; Parkinsonism; Psychosis; Psychiatry; Escitalopram; Randomized controlled trial; Medicine; Antipsychotic; Citalopram; Ziprasidone; Anticholinergic; Psychology; Antidepressant; Schizophrenia (object-oriented programming); Disease; Internal medicine; Anxiety","authors":[{"name":"Lamia Sid‐Otmane","is_ca":true},{"name":"Philippe Huot","is_ca":true},{"name":"Michel Panisset","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05376582530136106,"gpt":0.4460727770714156,"spread":0.3923069517700546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008214159,0.000596466,0.005138798,0.0001979894,0.00003212134,0.000004358295,0.00008623098,0.0002607652,0.0001139078],"category_scores_gemma":[0.001962956,0.0004305734,0.0008878226,0.0003910089,0.0002892992,0.00003813728,0.000143109,0.0007209472,0.00001138086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003278344,"about_ca_system_score_gemma":0.0002841343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006729384,"about_ca_topic_score_gemma":8.958197e-7,"domain_scores_codex":[0.9934382,0.002470583,0.002420188,0.001126919,0.0002339762,0.0003101413],"domain_scores_gemma":[0.9950637,0.002233318,0.001294821,0.0006339625,0.00006292293,0.0007112757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008614591,0.0005634112,0.00116464,0.1347588,0.000361763,0.5421366,0.000001463892,3.721874e-8,8.192113e-7,0.000002214719,0.0002056812,0.3199431],"study_design_scores_gemma":[0.00343507,0.006553295,0.0005248855,0.07996234,0.01798637,0.2028854,5.175788e-7,0.000008117873,0.000009304277,0.000006343569,0.6883305,0.0002978506],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07807425,0.9177726,2.311445e-7,0.00008949985,0.0007494939,0.00306353,0.0001851644,0.00002847637,0.00003677466],"genre_scores_gemma":[0.03100351,0.9678178,0.0000162148,0.0006670703,0.0001264066,0.0002240921,0.00004648669,0.00007746682,0.00002092397],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6881248,"threshold_uncertainty_score":0.9998146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987370838","doi":"10.1097/wnf.0b013e31815cba61","title":"Variability of the In Vivo Metabolism of Clozapine","year":2008,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Defense Medical College","keywords":"Clozapine; Metabolite; In vivo; Schizophrenia (object-oriented programming); Pharmacology; Antipsychotic; Atypical antipsychotic; Metabolism; Psychology; Chemistry; Endocrinology; Internal medicine; Medicine; Biology; Psychiatry","authors":[{"name":"Thomas J. Raedler","is_ca":true},{"name":"Kim Hinkelmann","is_ca":false},{"name":"Klaus Wiedemann","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07665838262348112,"gpt":0.4100766655505208,"spread":0.3334182829270397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005615302,0.00008405674,0.00051724,0.00005418027,0.00002108556,3.695384e-7,0.0001635215,0.00008056752,0.0005629626],"category_scores_gemma":[0.002001948,0.00005083713,0.0002220678,0.0002855138,0.0007051566,0.00001451984,0.0001295895,0.000392327,0.000008780518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001348568,"about_ca_system_score_gemma":0.0003169034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002493979,"about_ca_topic_score_gemma":0.000005531836,"domain_scores_codex":[0.9979559,0.0007754461,0.0006764967,0.0002274095,0.0001844074,0.0001803659],"domain_scores_gemma":[0.9978415,0.001463233,0.0001269653,0.0003378735,0.0001043763,0.000126013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01562015,0.004132464,0.9232877,0.00007292864,0.0001704233,0.0004202338,0.00004096327,0.000007640471,0.05090889,0.0008867818,0.001608127,0.002843631],"study_design_scores_gemma":[0.008808807,0.0004945427,0.9691529,0.000007324777,0.00008724402,0.00005073238,0.000001416715,0.00008497618,0.01898313,0.0002557912,0.002041205,0.00003193755],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966419,0.0001693548,0.000002167212,0.001906795,0.0004681236,0.0004098133,0.00001169975,0.000008389334,0.000381808],"genre_scores_gemma":[0.9978287,0.0009171294,0.000334309,0.000644516,0.0001149386,0.00001390638,5.943015e-7,0.000008219364,0.0001376942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04586511,"threshold_uncertainty_score":0.6164045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2396912542","doi":"10.1097/wnf.0000000000000107","title":"Comparison Between Dysport and Prosigne in the Treatment of Cervical Dystonia","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cervical dystonia; Dystonia; Medicine; Dermatology; Pediatrics; Psychiatry","authors":[{"name":"Pedro Barbosa","is_ca":false},{"name":"Daniel Sabino de Oliveira","is_ca":false},{"name":"Carolina Pinto Souza","is_ca":false},{"name":"Vítor Tumas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2095311718629328,"gpt":0.4772698150497375,"spread":0.2677386431868047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003805098,0.0001374673,0.0006611214,0.00004809719,0.0000218188,0.000003348481,0.0001123841,0.0002338781,0.000038322],"category_scores_gemma":[0.0001690092,0.00007558995,0.0001026374,0.0001870631,0.0005051902,0.0000148028,0.00003147532,0.0004591612,0.00002462933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001209798,"about_ca_system_score_gemma":0.0000577493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007502642,"about_ca_topic_score_gemma":0.000001830827,"domain_scores_codex":[0.9980506,0.0005469093,0.0007256212,0.0003138477,0.0001453999,0.00021768],"domain_scores_gemma":[0.9983108,0.001132265,0.0001154258,0.0001733603,0.00003976615,0.0002283737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001111162,0.003101184,0.9834014,0.00001762982,0.00005397011,0.0004089525,0.0002404641,0.000006426846,0.0005870168,0.00004702873,0.001059261,0.009965558],"study_design_scores_gemma":[0.007619351,0.01381213,0.9541191,0.000005151943,0.0002701319,0.00004363712,0.00004881324,0.0003054022,0.0002070508,0.0001445887,0.02335179,0.00007288027],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896165,0.0004822672,0.000003593819,0.008372956,0.0002648499,0.0006122497,0.000002923623,0.00002533369,0.0006193899],"genre_scores_gemma":[0.9953458,0.001172889,0.00005790928,0.003171336,0.0001490349,0.00001927136,0.000005923172,0.00001126926,0.00006661897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02928228,"threshold_uncertainty_score":0.3082469,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2329026659","doi":"10.1097/wnf.0000000000000067","title":"Effect of Midazolam on Memory During Fiberoptic Gastroscopy Under Conscious Sedation","year":2015,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Midazolam; Sedation; Anesthesia; Medicine","authors":[{"name":"Yun Jeong Hong","is_ca":false},{"name":"Eun Hye Jang","is_ca":false},{"name":"Jihye Hwang","is_ca":false},{"name":"Jee Hoon Roh","is_ca":false},{"name":"Miseon Kwon","is_ca":false},{"name":"Don Lee","is_ca":false},{"name":"Jae‐Hong Lee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06420667134097428,"gpt":0.4356038684814592,"spread":0.3713971971404849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005877953,0.0001595756,0.000545349,0.00007896133,0.00003435626,0.000003425778,0.0001010318,0.0001219207,0.0001663957],"category_scores_gemma":[0.0007079114,0.000124651,0.0001438812,0.0001078567,0.0003048892,0.00003463755,0.00004521427,0.0003902068,0.0003016839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003597388,"about_ca_system_score_gemma":0.00009251838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001895111,"about_ca_topic_score_gemma":2.195028e-7,"domain_scores_codex":[0.9977934,0.0009324547,0.0005117769,0.0003310106,0.0002003576,0.0002309403],"domain_scores_gemma":[0.9977763,0.001428317,0.0001736006,0.0002159758,0.0001034158,0.0003024085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.04609315,0.002935119,0.4478742,0.0007075943,0.0005405389,0.003414051,0.0002150365,0.0006357946,0.479757,0.0001099622,0.01190666,0.005810885],"study_design_scores_gemma":[0.04229973,0.04419882,0.6097384,0.0001464577,0.001172537,0.0004282954,0.00007079088,0.001234639,0.2991039,0.00004338233,0.001191654,0.000371358],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972273,0.00002794099,0.00001468386,0.0007958735,0.0007366025,0.0004695015,0.000001705946,0.00004936639,0.0006770264],"genre_scores_gemma":[0.9961888,0.00003465291,0.00006814164,0.002866339,0.0002687736,0.00001298241,0.00000871006,0.00002580183,0.0005258456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.180653,"threshold_uncertainty_score":0.5083122,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4309181475","doi":"10.1097/wnf.0000000000000528","title":"Protective Effects of Ursodeoxycholic Acid Against Oxidative Stress and Neuroinflammation Through Mitogen-Activated Protein Kinases Pathway in MPTP-Induced Parkinson Disease","year":2022,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"MPTP; Ursodeoxycholic acid; Oxidative stress; Pharmacology; Neuroinflammation; Superoxide dismutase; Chemistry; Endocrinology; p38 mitogen-activated protein kinases; Internal medicine; Kinase; Medicine; Dopamine; Protein kinase A; Biochemistry; Inflammation; Dopaminergic","authors":[{"name":"Chenggong Jiang","is_ca":false},{"name":"Dongfang Shen","is_ca":false},{"name":"Kaiyang Li","is_ca":true},{"name":"Huan Wang","is_ca":false},{"name":"Wenxu Sang","is_ca":false},{"name":"Huiping Qi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03706120007032836,"gpt":0.3400274841243841,"spread":0.3029662840540557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002022505,0.0003093568,0.0006690362,0.0001669306,0.0001503264,0.000009297431,0.0001451349,0.00009491949,0.00005178417],"category_scores_gemma":[0.0009600529,0.0002926258,0.0001679118,0.0004026133,0.0001625274,0.0001292789,0.0002465332,0.0007113349,0.000005784253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009405328,"about_ca_system_score_gemma":0.0002397979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002977331,"about_ca_topic_score_gemma":0.00000346708,"domain_scores_codex":[0.9961181,0.001719334,0.0006656526,0.0008165325,0.0003106257,0.0003697154],"domain_scores_gemma":[0.9983066,0.000554893,0.0004227859,0.0002996454,0.0000851798,0.0003309327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007841312,0.003907055,0.01131363,0.0003909961,0.0002034819,0.003583983,0.0002385658,0.00001956969,0.9598539,0.0001106371,0.00001509939,0.01252173],"study_design_scores_gemma":[0.01126555,0.003745067,0.2803085,0.0001235374,0.0001970482,0.00001016804,0.0000520238,0.0002614074,0.7024179,0.0004557746,0.0009338951,0.000229165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944649,0.0003120978,0.00002245494,0.0004001964,0.0005951041,0.003974264,0.0001277566,0.00007149033,0.00003173104],"genre_scores_gemma":[0.9973961,0.0001112708,0.00007570032,0.0007416265,0.00009815846,0.001441907,0.00006303513,0.00005106318,0.00002115486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2689949,"threshold_uncertainty_score":0.9999526,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}